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ABSTRACT
Objectives Little is known about the management of 
female genital mutilation (FGM) in primary care. There 
have been significant recent statutory changes relevant 
to general practitioners (GPs) in England, including a 
mandatory reporting duty. We undertook a realist synthesis 
to explore what influences how and when GPs discuss 
FGM with their patients.
Setting Primary care in England.
Data sources Realist literature synthesis searching 
10 databases with terms: GPs, primary care, obstetrics, 
gynaecology, midwifery and FGM (UK and worldwide). 
Citation chasing was used, and relevant grey literature was 
included, including searching FGM advocacy organisation 
websites for relevant data. Other potentially relevant 
literature fields were searched for evidence to inform 
programme theory development. We included all study 
designs and papers that presented evidence about factors 
potentially relevant to considering how, why and in what 
circumstances GPs feel able to discuss FGM with their 
patients.
Primary outcome measure This realist review developed 
programme theory, tested against existing evidence, on 
what influences GPs actions and reactions to FGM in 
primary care consultations and where, when and why 
these influences are activated.
Results 124 documents were included in the synthesis. 
Our analysis found that GPs need knowledge and 
training to help them support their patients with FGM, 
including who may be affected, what needs they may 
have and how to talk sensitively about FGM. Access to 
specialist services and guidance may help them with 
this role. Reporting requirements may complicate these 
conversations.
Conclusions There is a pressing need to develop 
(and evaluate) training to help GPs meet FGM- affected 
communities’ health needs and to promote the 
accessibility of primary care. Education and resources 
should be developed in partnership with community 
members. The impact of the mandatory reporting 
requirement and the Enhanced Dataset on healthcare 
interactions in primary care warrants evaluation.
PROSPERO registration number CRD42018091996.
INTRODUCTION
Female genital mutilation (FGM) is defined 
as all procedures that intentionally alter 
or cause injury to the female genitalia for 
non- medical reasons. There are no known 
health benefits and many documented 
harms, including immediate and long- term 
physical and psychological consequences. 
FGM is recognised internationally as an act 
of violence against women and girls. FGM 
is categorised into four types: type I (clito-
ridectomy), type II (partial or total removal 
of the clitoris and labia minora/majora), 
type III (infibulation) and type IV (all other 
harmful procedures, including pricking and 
piercing).1
UNICEF estimates that 200 million girls 
and women in 30 countries worldwide have 
been subjected to FGM. Global migration 
from areas where FGM is traditionally prac-
tised means that FGM is now a worldwide 
health concern.2
In 2011, it was estimated that 137 000 
women and girls with FGM from countries 
Strengths and limitations of this study
 ► A realist approach to synthesis facilitated inclusion 
of a wide range of data sources and consideration 
of this research question despite little direct primary 
care research about female genital mutilation, with 
a comprehensive and iterative approach to data 
searching for relevant evidence.
 ► This method facilitated the inclusion of community, 
charity and advocacy organisation data contributing 
evidence that might not have been accessible using 
other methods.
 ► We searched widely for data to inform the question 
in comparative fields.
 ► The tabulation and characterisation of the published 
research are themselves valuable and highlight po-
tential research gaps.
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where FGM is traditionally practised were permanently 
resident in England and Wales. Prevalence of FGM was 
thought to be highest in urban areas, but women and girls 
affected by FGM were likely to live in every local authority 
area in England and Wales.3
In 2014, the UK government hosted the first Girl 
Summit, in partnership with UNICEF, at which they 
pledged to mobilise domestic and international efforts 
to stamp out FGM within a generation, launching a raft 
of initiatives, including a £1.4 million FGM prevention 
programme with NHS England, and legislative changes.4 
The FGM prevention programme sought to improve how 
the NHS responds to FGM,5 and sets out expectations for 
NHS staff, including about data recording.6
FGM has been a specific offence in the UK since 1985.7 
Before 2019 there had been no UK convictions, with the 
lack of progress tackling FGM described as a ‘national 
scandal’ in 2014 by a Home Affairs Select Committee 
reporting on the case for an FGM National Action Plan 
(with aims including achieving a successful prosecution 
and improving safeguarding and services).8 In 2015, a 
mandatory reporting duty was introduced in England 
and Wales, requiring all registered professionals to report 
all cases in under 18 year olds where FGM was identi-
fied on examination or through a first- hand disclosure 
directly to the police.9 Additionally, an FGM Enhanced 
Dataset was introduced in 2015 in England, mandating 
the submission of quarterly data returns, including 
personally identifiable data from all general practitioner 
(GP) practices.10 Data return rates from primary care to 
the Enhanced Dataset have been low, with only 64 GP 
practices in England submitting data returns in 2018–
2019.11 The reasons for this are not known. Concerns 
have been raised by clinicians and community members 
about the potential impacts of mandatory reporting 
and the Enhanced Dataset on trust and patient–doctor 
relationships.12–15
In this realist synthesis, we seek to understand factors 
that can potentially influence how GPs and women and 
girls from FGM- affected communities interact in English 
primary care in the current UK context. This was identi-
fied as an important area for exploration in a research 
user consultation where community members and 
professionals were asked what they identified as FGM 
research and service priorities.16 General practice care 
in England is typically delivered by primary care health 
teams, including GPs, practice nurses, advanced nurse 
practitioners (ANPs) and, increasingly, pharmacists 
and paramedics who are based in GP practices located 
within community settings. Primary care in England 
holds patients and families in holistic and longitudinal 
care (and care records) and has a gatekeeper role. Prior 
systematic reviews have shown that around the world, 
health professionals do not have adequate knowledge 
about FGM, although these reviews primarily focused on 
obstetrics and gynaecology.17 18
Our exploratory review identified the relevant liter-
ature as disparate and heterogeneous. Therefore, we 
identified a need for bringing together and making sense 
of different types of evidence that would help develop our 
understanding of how, why and under what circumstances 
FGM is discussed (or not) in primary care consultations 
in England, in the context of recent policy changes.
To explore this overarching review aim, we identified 
the following review questions:
1. What influences how GPs manage FGM in their clini-
cal practice and why?
2. What influences GPs’ actions when they consider ini-
tiating discussion about FGM with patients in primary 
care? Where, when and why are these influences ac-
tive?
3. What influences how GPs respond to a patient- initiated 
disclosure of FGM during a primary care consultation? 
Where, when and why are these influences active?
METHODS
For GPs, supporting women with FGM and managing the 
attendant reporting, safeguarding and clinical needs asso-
ciated with this can be viewed as a complex intervention 
(defined by the Medical Research Council as an interven-
tion with several interacting components, and where the 
behaviours required by the intervention are numerous or 
complex19).The FGM Prevention Programme included 
the provision of new educational materials, safeguarding 
resources and new obligations to document and report 
FGM. This requires GPs to participate in educational 
opportunities, consider when and how to discuss FGM 
with their patients, and consider when and how they need 
to comply with reporting requirements.
Realist synthesis is a theory- driven and interpretive 
systematic review methodology with an explanatory rather 
than judgemental focus which can be used to evaluate 
the impact of complex policy. Adopting a realist synthesis 
methodological approach, the research question does not 
only explore whether an intervention works—or not—
but explicitly considers under what circumstances (when, 
why and how) an intervention might generate outcomes. 
A realist synthesis seeks to explore the contexts under 
which outcomes occur, and the mechanisms (processes 
which connect the context and the outcome) which link 
them.20
There is little primary research about how English 
GPs are managing their patients with FGM. The realist 
review approach as defined by Realist and Meta- narrative 
Evidence Syntheses Evolving Standards (RAMESES) 
allows development of programme theory based on 
evidence about managing FGM in other healthcare 
settings (eg, obstetrics and midwifery), from grey litera-
ture, including opinion pieces and charity publications, 
and for testing evolving programme theory in potentially 
comparable healthcare challenges in English primary 
care.
We used the RAMESES publication standards to 
develop21 and report this realist synthesis,22 and followed 
methodology described in other realist syntheses.23 The 
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study was registered on prospero and the protocol is avail-
able in online supplemental appendix 1.
Patient and public involvement (PPI)
This synthesis was developed following a patient and 
public involvement research priority setting project, 
in which SD was involved in developing and reporting, 
which identified this question as a research priority.16 The 
findings of this synthesis were reviewed with stakeholders 
and PPI collaborators who commented on resonance and 
relevance.
Initial programme theory development
An initial programme theory (a theory describing how 
and why the interventions being considered are hypothe-
sised to operate to generate outcomes)22 considering how 
and under what circumstances GPs in England might talk 
about FGM with their patients was derived by SD based 
on an exploratory literature review and relevant policy 
documentation (online supplemental appendix 2). SD 
works as a GP partner and is a practice safeguarding lead. 
Since 2015, SD has been a primary care member of her 
local safeguarding board FGM operational group. SD is a 
trustee of Oxford Against Cutting. This synthesis was devel-
oped by SD following a public and stakeholder research 
priority setting project which identified service priori-
ties (including the need for holistic services throughout 
the life course) and research questions, including the 
potential impacts of mandatory reporting and the FGM 
Enhanced Dataset on trust in healthcare. Following the 
commencement of this literature synthesis, SD developed 
and began a qualitative study undertaking interviews 
with GPs about their perspectives on supporting women 
affected by FGM in the context of English primary care 
following the introduction of mandatory reporting and 
the FGM Enhanced Dataset. An expert advisory group 
consisting of six primary healthcare professionals (HCPs), 
including local and national FGM experts, acted as 
project stakeholders and advised on how the programme 
theory fitted within primary care processes, a recognised 
contribution to realist synthesis.24
Searching
Searching for data for inclusion in this review was 
conducted in multiple stages. Initial exploratory scoping 
searches identified an initial set of relevant docu-
ments which informed the development of the initial 
programme theory and contributed to theory refine-
ment. The main searches to identify evidence to test 
our programme theory were developed by an informa-
tion specialist and conducted in the following databases: 
MEDLINE, Embase, PsycINFO, Global Health, CINAHL, 
Web of Science, Sociological Abstracts, Anthropology 
Plus, Social Science Abstracts and ASSIA. We searched 
for literature on health professionals and FGM in the UK 
and worldwide, in primary care and obstetrics and gynae-
cology, and we searched for international qualitative 
studies and reviews on FGM. There was no time limit set 
for the search. We included other health settings where 
the reporting and communication requirements might 
be similar because of the lack of primary care data. We 
built our dataset iteratively by searching reference lists 
and conducting forward citation searches for key papers. 
We included grey literature identified in this way and 
used recommendations from experts in FGM, including 
systematically searching for reports from English FGM 
advocacy organisations. We conducted update searches 
to ensure that the most recent evidence was included. 
We also conducted secondary searches in the following 
bodies of literature, identified as areas where compa-
rable contexts and mechanisms may occur to inform our 
developing programme theory: intimate partner violence 
(IPV) in primary care, Driving & Vehicle Licensing 
Agency (DVLA) reporting, the Prevent programme and 
mandatory reporting (in health and education). The 
searches are available in the online supplemental file 
(online supplemental appendix 3).
Selection and appraisal of documents
We included all study designs and papers that presented 
evidence about factors potentially relevant to considering 
how, why and in what circumstances GPs feel able to discuss 
(or not) FGM with their patients in English primary care 
settings, following the recent regulatory changes. Where 
documents from non- UK settings were identified, we 
excluded those written in languages other than English 
and from contexts likely to be significantly different 
from UK primary care. We included opinion pieces in 
influential UK medical journals as these could provide 
explanations relevant to UK primary care. All titles and 
abstracts were screened by SD and were included for full- 
text review if they were judged as potentially containing 
information relevant to conversations about FGM in 
primary care. Papers that contained information possibly 
informative about any part of the process of primary care 
consultation were considered. Our scoping had shown 
us that there was no primary evidence that covered all 
aspects of our review question, and so we identified that 
to having broad and open criterion would facilitate the 
development of responsive and wide- ranging programme 
theory. In keeping with realist methodology, data selec-
tion and inclusion were iterative, beginning with our 
initial programme theory and then revisited as new areas 
of theory emerged. For example, as emotive responses to 
FGM emerged as an important relevant factor from our 
initial searching, we revisited our search for evidence to 
explore this, as is established in realist synthesis method-
ology.20 In keeping with realist synthesis methodology, 
papers were appraised for their relevance (whether the 
study provided evidence relevant to the theory under 
development) and rigour (whether the inferences within 
the evidence make a credible contribution to testing 
a developing theory). The concept of data saturation 
is applicable within realist synthesis.20 Together, these 
methodological parameters made up the study frame-
work, which determined inclusion and exclusion. Ten per 
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cent of selected abstracts were independently reviewed by 
GH/CD and discrepancies were discussed to inform the 
remaining screening process. All included full- text docu-
ments were reviewed and inclusion was agreed with GH/
CD/study team.
Data extraction and analysis
Papers selected for full text review were loaded into 
NVivo and coded. We based initial codes on the initial 
programme theory, adding further emergent codes 
during analysis. We examined the coded data for patterns 
(demiregularities25) from which we identified potential 
contexts, mechanisms and outcomes of interest. These 
were iteratively examined within the evidence to develop 
configurations of contexts, mechanisms and outcomes 
(CMOCs). The expert advisory group commented on 
the resonance of the developing and finally presented 
CMOCs. We prioritised high- quality empirical data; 
however, we included evidence from other sources if it 
was relevant to the developing primary care CMOCs.20 26 
The resulting programme theory was developed in realist 
format depicting the relationship between context, 
outcome and the mechanism linking them. Developing 
theory was tested for resonance by considering it against 
evidence from comparative literature fields.24
RESULTS
In the searching directly related to FGM (including the 
scoping, main and update searches), 4035 abstracts were 
identified and screened, leading to a full- text review of 
346 papers, with an additional 51 papers added for full- 
text review from recommendation, advocacy organisation 
searching and citation tracking, leading to the final inclu-
sion of 94 papers from the FGM literature. Comparative 
literature was identified from the secondary searches 
from UK primary care in IPV, the Prevent strategy, DVLA 
reporting and mandated reporting. Reading within the 
Prevent literature, we identified evidence related to data 
sharing in the context of immigration enforcement, and 
this was also included where relevant; these searches 
identified 593 citations, of which 121 were included for 
full- text review, and 30 informed the synthesis. Figure 1 
summarises the search strategy; table 1 summarises the 
characteristics of the included FGM evidence and table 2 
summarises the characteristics of the included evidence 
from the comparative literature.
This section is a narrative account of the final 
programme theory (explanatory configurations of 
contexts, mechanisms and outcomes) developed by this 
synthesis considering how, why and under what circum-
stances GPs might initiate (or not) or respond to FGM 
(or not) in the setting of English primary care. A full set 
of CMOCs with supporting data is available as a supple-
mentary file (online supplemental appendix 4). The 
programme theory is presented within four themes: FGM 
knowledge and awareness, communication about FGM, 
the role of guidelines and service provision, and manda-
tory reporting requirements. The overarching realist 
Figure 1 Summary of our searching and screening processes. Tables 1 and 2 summarise the characteristics of the papers 
included in the synthesis. DVA, domestic violence and abuse; DVLA, Driving & Vehicle Licensing Agency; FGM, female genital 
mutilation; IPV, intimate partner violence.
 on A









pen: first published as 10.1136/bm





5Dixon S, et al. BMJ Open 2021;11:e039809. doi:10.1136/bmjopen-2020-039809
Open access
programme theory is illustrated graphically at the conclu-
sion of the results section.
FGM knowledge and awareness
Health professionals need to have adequate knowledge 
about FGM to meet the care needs of patients who may 
be affected by FGM (including having had FGM or poten-
tially being at risk of FGM).17 18 27–47 Awareness of who 
might be affected by FGM, as well as the different types 
of FGM and their associated clinical consequences, will 
influence whether GPs identify a need to consider or 
ask about FGM with their patients. Health professionals 
also need to know about relevant legislation, and their 
statutory and safeguarding requirements in relation to 
FGM.17 18 33 34 38 41 47–49
Whether GPs are aware (or not) of what they may not 
know about FGM, lacking knowledge about FGM affects 
practitioners’ ability and confidence when caring for 
women with FGM,36 50 51 including confidence to consider 
who may be at risk.52 Knowing how to respond to a disclo-
sure or when identifying that a woman has FGM may 
help GPs feel confident to ask.53 54 In turn, women who 
perceive that GPs do not have the knowledge or skills 
to recognise their FGM- related care needs, or who feel 
potentially stigmatised because of their FGM, may lack 
confidence in accessing healthcare.31 36 50 55–59
Health professionals report experiencing strong 
emotional reactions to encountering FGM, including 
anger, shock and pity,47 60–62 and that seeing FGM without 
having adequate knowledge can be ‘frightening’.61 Expe-
riencing these strong emotional responses may contribute 
to clinicians feeling panicked, and abandoning usual prac-
tices and routines.54 63 Although professionals describe 
trying to hide their reactions, they were aware that they 
may be apparent to the women.45 61 This observation is 
mirrored by evidence from community members who 
describe feeling ashamed or judged when HCPs react 
with shock or horror to their FGM, notably during phys-
ical examinations.55 64–68 This can impact on their will-
ingness to access services,46 64–67 including attending for 
cervical smears.69 This could be mitigated against when 
professionals were able to act with confidence and sensi-
tivity.54 67 70
Health professionals with experience of supporting 
patients with FGM were likely to have more knowledge 
about FGM.34 38 40 71 A potential challenge for GPs is that 
FGM may form only a small part of their workload,14 72 73 
meaning that learning about FGM may not be identified 
as a priority.
Another potential difficulty is that FGM can be chal-
lenging to identify.74 Recent data from a specialist paedi-
atric clinic in England noted that the examination signs 
in type IV can be subtle and potentially difficult to iden-
tify,75 76 or be associated with minimal or non- specific 
symptoms.75 77 Others have noted that not all GPs will have 
the necessary expertise to identify all types of FGM.12 78 
Added to this complexity is that self- reporting by women 
about their FGM type in health settings has been shown 
Table 1 Characteristics of the 94 papers making up 
the FGM literature evidence which contributed to CMOC 
derivation






Other (eg, editorial opinion piece) 17
Country of research origin
  UK 35
  Other European 21
  America/Canada 5
  Australia 4
  Africa 1
Whose perspective
  Provider 29
  Community 28
  Both 10
Details of providers
  Obstetrics/gynaecology / midwifery 21
  Other secondary care 11
  Mixed, including primary care 6
Country of origin of women research 
conducted with/included
  Somalia/infibulated women/type III FGM 23
  Mixed African 12
  Mixed 2
CMOC, context, mechanism and outcome; FGM, female genital 
mutilation.
Table 2 Characteristics of the 30 papers included from 
literature identifies in secondary searches
Characteristics Papers (n)
Intimate partner violence
  Primary qualitative 8





  Primary qualitative 4
  Primary quantitative 4
  Other/opinion/guidance/review 2
Prevent strategy/data sharing
  Primary qualitative 2
  Primary quantitative
  Other/opinion/guidance/review 3
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not to be reliable,79 which could impact on how women 
feel able to respond to some questions about FGM.
Talking about FGM and communication
A key skill GPs need is being able to talk about FGM sensi-
tively.36 45 80 GPs who do not feel confident in raising the 
subject of FGM, for example, because they are worried 
that they will upset or offend women, may avoid talking 
about FGM.14 30 42 46 47 49 55 61 64 74 80 81 Health professionals 
who perceive that discussing FGM can be culturally taboo 
or a sensitive subject could also be fearful of offending 
women reported sometimes avoiding talking about 
FGM,14 47 80 82 as may women.55 83 This was described in 
one study as an ‘expression of respect’.80 This contextual 
factor may be evolving as community attitudes towards 
talking about FGM are shifting,48 63 84 85 including that 
talking about FGM is becoming less taboo in some 
communities.86–88 Lacking awareness of shifting commu-
nity attitudes can risk offending or alienating members of 
those communities,28 48 63 85 which risks reducing effective 
communication.
The words or terminology that GPs use when they talk 
about FGM can complicate communication with their 
patients. For example, if the term FGM is not familiar to 
the woman,89 90 offends or alarms her,50 91 or she does not 
align her cultural practice (eg, labial elongation) with 
FGM,92 then she may not relate her experience to FGM. 
This can complicate conversations about the potential 
health consequences of FGM or whether women perceive 
the conversation is relevant to their experience of FGM.93
Women who were aware of previous difficult expe-
riences with communication and engagement with 
health professionals (eg, language, cultural differences, 
perceived judgement) where they had not felt under-
stood or respected describe a lack of confidence and trust 
in health services.45 55–57 64 94 Women who feel pitied or 
judged may be less likely to feel able to make a disclosure 
to HCPs.95 96 Language barriers or a lack of understanding 
about how health services work, including negotiating 
with primary care reception staff can complicate access 
to healthcare.97
A potential strategy that could help facilitate both the 
acceptability and accessibility of services is the involve-
ment of community health advocates, such as members 
of FGM- affected communities, who can act as a bridge 
between communities and services, for example, by 
promoting trust and providing education for both 
community members and health professionals.16 98 99
For GPs, whether FGM is raised by the patient or the 
GP, an important contextual factor is whether FGM is 
perceived to be relevant to the health concern which the 
woman brings to her GP appointment. This can influence 
both whether the subject of FGM is broached, and then if 
broached, how it is received and experienced.48 62 84 90 100 
Women who feel that the HCP is preoccupied with their 
FGM, rather than their health concerns, may disengage 
from the healthcare setting.48 84 101 102 This is also poten-
tially relevant when GPs consider asking women about 
their experience of FGM with the aim of considering the 
safeguarding needs within their families, rather than the 
woman’s own health needs.48 53 63 73 103 104 Balancing the 
needs of the woman who is presenting with the potential 
needs of her wider family may introduce complex consid-
erations for GPs when they are considering how and into 
whose medical notes they code FGM into primary care 
medical records.104–106
An important context which influences how able (and 
enabled) GPs and their patients are to effectively commu-
nicate about FGM is whether there is a language barrier 
between them or not.14 18 30 45 47 55 81 82 97 107–109 Strategies to 
address language barriers add their own complications. 
Official interpreters are recommended, but may not be 
available or trusted by women, for example, if they both 
perceive FGM as taboo, or she fears they will not respect her 
confidentiality. This can lead to fear and reduced engage-
ment with health professionals.14 30 32 47 49 61 62 69 110 111 The 
presence of family members (as interpreters or witnesses) 
in the consultation may inhibit GPs from feeling able to 
raise FGM with the women because of concerns about 
privacy and confidentiality.14 30 82 112
Finally, factors such as the GP’s gender may influence 
whether the woman or GP feel it is culturally appro-
priate to talk about FGM.14 47 69 107 Time constraints in 
the consultation may act as a potential barrier which 
deters GPs when they are contemplating discussing 
FGM.14 47 50 73 113
Need for guidelines and access to specialist services
Researchers and commentators suggest that having access 
to clear guidelines will enable professionals to ask women 
about FGM and optimise their care.17 44 47 61 63 114 However, 
even when guidelines exist, awareness of them may be 
incomplete or they may not be followed, as demonstrated 
by four UK hospital studies.49 71 81 115 Access to guidance 
and specialist services may be especially important for 
clinicians who see FGM less often.47 Lacking guidance, 
including a lack of certainty of what ‘good care’ comprises, 
can lead clinicians to feel unsure and to improvise how 
they offer care,46 47 and risks ethical dilemmas or incor-
rect decision making.63 114
Normalising asking about FGM, for example, by using 
prompts in the medical record, may overcome some clini-
cian barriers and help them begin these discussions,116 
especially if these are then linked to resources or care 
pathways.117
Having access to services which could offer specialist 
assessments, treatment or advice may help GPs feel 
enabled to raise the subject of FGM.12 47 55 57 78 118 When 
health professionals speak about FGM within a frame-
work of offering support and services, it is more likely to 
be experienced as acceptable by their patients.88 When 
training and education are supported by referral path-
ways or protocols for intervention, they are more likely to 
be effective in changing behaviour and promoting clini-
cians asking.54 95 117 119
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Mandated actions including the mandatory reporting duty and 
the FGM Enhanced Dataset requirements
It is unknown what impact the FGM reporting 
duties have on healthcare interactions, but concerns 
have been raised that approaches to safeguarding 
including the mandatory reporting duty in FGM may 
cause women distress or reduce their trust in HCPs, 
which may deter women from seeking healthcare or 
disclosing their FGM to HCPs.12 13 84 86 120 121 Further-
more, if women perceive that the HCP is more inter-
ested in data management about their FGM than 
their needs, they may feel disrespected and may avoid 
healthcare settings.84
The requirement to send personally identifiable 
data to the FGM Enhanced Dataset was also identified 
as a potential barrier to talking about FGM by both 
women and GPs.14–16 84 122 123 When women are not 
confident that their medical encounters or records 
are confidential, they may feel fearful and avoid 
making disclosures.112 124
The concern that making a mandated report would 
have a negative impact on ongoing effective doctor–
patient relationships may be an important consider-
ation for professionals,125–129 including whether this 
might deter patients from accessing services.126 130 
Lacking confidence that making a mandated report 
will be met with an acceptable or adequate response 
may pose challenges for HCPs.128 131
Practitioners may need to feel certain before 
making a mandated report,128 132 133 and challenges 
in identifying less apparent forms of FGM may 
add tensions to the requirements for mandated 
reporting.128 In the case of FGM, this could be compli-
cated if GPs do not feel confident that they have the 
knowledge or skills to correctly identify FGM,74 75 
especially types I and IV, which may be both harder to 
visualise on examination and more commonly encoun-
tered.75 76 134 135 Mandatory reporting by health profes-
sionals should be supported by educational resources 
and training;133 135 reporting without training may lead 
to inaccurate data collection.136 Clinician concerns 
about confidentiality and stigma could also contribute 
to incomplete or inaccurate data coding.137
When young people know that the professional 
whom they are speaking to is mandated to share the 
information with other authorities, they may feel more 
reluctant to trust the professional and may be less 
likely to make a disclosure.138 Those who are poten-
tially fearful of authorities or perceive themselves to be 
vulnerable, for example, those with uncertain migrant 
status, may be more fearful of mandatory reporting or 
data sharing and may avoid accessing services.139–143
Overarching programme theory
Figures 2 and 3 bring together the emerging CMOC 
configurations that made up the programme theory 
for this review and depict a theoretical framework for 
how these might inter- relate, thus offering a conceptual 
summary of this synthesis.
Figure 2 Conceptual depiction of factors that may influence when GPs may or may not talk about FGM with their patients. 
FGM, female genital mutilation; GP, general practitioner.
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GPs need adequate knowledge to support their patients 
with FGM, including the different FGM types and their 
different clinical presentations, needs and cultural 
contexts. This includes needing to be aware of local 
legislative, statutory and safeguarding requirements. GPs 
need skills to discuss FGM sensitively and with appro-
priate terminology. Language barriers can complicate 
conversations about FGM. Access to official interpreters 
is recommended, but they may not always be available. 
Even when available, there are potential pitfalls which 
GPs should be aware of, including consideration of who 
else is present in the consultation. The requirements of 
mandatory reporting and the FGM Enhanced Dataset 
may bring additional complications into the primary care 
consultation. Community health advocates could have a 
role in facilitating access to services.
Strengths and limitations
As illustrated by table 1, only limited evidence was 
directly relevant to primary care. GPs have a vital role in 
managing FGM, yet there is little evidence about their 
attitudes, knowledge or behaviour towards managing 
FGM in primary care, and none in the context of the 2015 
policy changes. This synthesis therefore uses evidence 
from provider experiences in other healthcare settings, 
predominantly specialist clinics, and obstetrics and gynae-
cology services. Some challenges are likely to be compa-
rable between these settings and primary care, namely, 
needing adequate knowledge and managing challenges 
with language and communication. However, there are 
differences between primary and secondary care that 
may limit this extrapolation, for example, that in obstet-
rics, FGM will almost always be relevant to the woman’s 
reason for attendance, which is not the case in general 
practice. To address this lack of direct evidence, we have 
also undertaken a primary qualitative study with GPs.144 
The lack of primary data about GPs necessitated complex 
searches and we may have inadvertently not identified 
important evidence.
We identified limited evidence on the experiences and 
needs of women from outside of Africa and with forms 
of FGM other than type III. Given the evidence that 
these types may not be those that GPs most commonly 
Figure 3 Conceptual diagram illustrating the overarching programme theory for this synthesis. FGM, female genital mutilation.
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encounter, this is a potentially significant limitation. 
Whether these findings can be extrapolated to inform 
healthcare for women with different FGM types or from 
other FGM practising countries (eg, Malaysia or Indo-
nesia) is unclear.
The GP consultation represents a coming together of 
GP and patient, and a strength of this synthesis is that it 
explores whether GPs talk about FGM using experiential 
evidence from both perspectives. Realist methodology 
allowed us to generate explanatory programme theory 
relevant to GPs from evidence on managing FGM in other 
healthcare settings and within other healthcare contexts, 
despite the lack of primary care data. Realist methodology 
supports the inclusion of grey literature. This project has 
benefitted from information on English community and 
GP perspectives reported by FGM advocacy organisations, 
which may not have been included in a traditional system-
atic review. Using iterative searching and citation tracking 
maximised data inclusion.
Comparison with existing literature
The FGM literature is predominantly descriptive. This 
helps define potential challenges but offers less evidence 
about effective interventions with which to address them.
There is a rich literature about FGM, including a number 
of previous systematic reviews and qualitative metasyn-
theses, including a number cited within this synthesis 
as contributing evidence, perspectives and commentary 
relevant to this synthesis question and research objec-
tives.17 18 43–47 65 102 This review includes other syntheses, 
which included grey literature,47 and evidence syntheses 
that included both provider and community perspec-
tives.45 46 In addition to their review of healthcare provider 
perspectives, Evans et al145 have undertaken a compre-
hensive systematic qualitative synthesis of women affected 
by FGMs experiences of healthcare. This wide- ranging 
review included grey literature and considered experi-
ences across all healthcare settings, including primary 
care. Their model of culturally safe care resonates with 
the realist theory we propose in this paper, as do their 
findings including the importance (and potential chal-
lenges) of effective communication, the value of positive 
encounters characterised by knowledge and compassion, 
and the adverse impacts on women when HCPs react to 
their FGM in ways which made them feel ashamed or 
judged.
This synthesis can add to this important developing 
body of literature by contributing a realist perspective, 
thus considering contextual and generative mechanisms 
across a range of processes potentially relevant to commu-
nication within the context of a primary care consul-
tation. Using grey literature and opinion pieces and 
bringing together evidence from provider and commu-
nity perspectives allowed us to triangulate possible influ-
ential factors. Finally, the realist methodology supported 
the inclusion of evidence from other research fields. This 
allowed us to postulate theory where there was no directly 
available evidence. For example, Evans et al47 noted in 
their synthesis of factors relevant to healthcare provision 
of FGM healthcare from the perspectives of healthcare 
providers that there was no evidence about the delivery 
of safeguarding care. Using insights from evidence about 
IPV offered potential evidence to test our tentative CMOC 
with and support their development, for example. about 
what helps clinicians in responding to disclosures,53 54 
and about the tensions experienced by GPs in their role 
of coding into the longitudinal patient care record.104–106 
This synthesis adds consideration of the potential impacts 
of mandated reporting and data sharing on communica-
tion in primary care consultations.
In this synthesis, we present postulated programme 
theory about any factors that might be relevant in the 
dynamics of the primary care setting, which we hope will 
be further tested, appraised and improved.
Indeed, since we submitted this synthesis, a qualita-
tive study exploring women with FGM’s experiences of 
primary care in the Netherlands has been published, 
which is a welcome addition to the available literature. 
This study reported women’s perceptions of challenges 
when seeing a GP, including concerns that their GP would 
not have adequate knowledge about FGM or would not 
be able to help them, and concerns about limited time in 
appointments. Satisfaction was increased when GPs were 
able to convey that they understood and were supportive 
of their care needs.146 We consider that these findings 
resonate with the theory postulated in this synthesis. As 
documented previously, following and then in parallel 
with conducting this synthesis SD/SZ have conducted 
a qualitative study exploring GPs working in England’s 
perspectives on supporting patients and families who 
might be affected by FGM. This study provides evidence 
which further supports the theory presented in this 
synthesis, including the need for holistic education about 
FGM, GPs concerns about identifying some forms of FGM 
on examination, and about knowing how to approach 
conversations about FGM with sensitivity and appropriate 
terminology. Holding responsibility for women’s care 
needs in parallel with their responsibilities for managing 
any potential safeguarding needs in her family could be 
challenging for GPs. The mandatory reporting and FGM 
Enhanced Dataset reporting requirements could further 
complicate these care journeys, alongside concerns about 
the impacts of these duties on enduring primary care 
relationships. Specialist services were seen as critical for 
enabling these conversations in primary care.144
In their realist synthesis considering the experiences 
of UK maternity care by women with social risk factors, 
which included consideration of women with FGM, 
Rayment- Jones et al147 also identified the importance of 
perceptions of kindness and respectfulness from HCPs, 
the value of trusting relationships and potential role for 
health advocates, and how factors such as language and 
access to interpreters contribute to the concept of candi-
dacy for care. This review also identified fear of judge-
ment by HCPs and perceptions of the health service 
role as surveillance rather than care were important 
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contextual factors relevant to accessing care. In their 
systematic review considering challenges and facilitators 
for refugees and asylum seekers in high- income coun-
tries, Robertshaw et al148 also identified the importance 
of trusting relationships, acceptable and accessible inter-
preters where there were language barriers, and the 
importance of cultural competency in primary care, and 
the need for education and training to support this. A 
2020 qualitative study exploring English healthcare 
providers’ perspectives on the impacts of data sharing 
for immigration enforcement reported concerns about 
impacts on health access, patient/clinician relationships, 
and about the interface between policy and their profes-
sional ethics, notably confidentiality and trust.149
The lack of (and need for) an evaluation of mandatory 
reporting has been commented on by other authors.150
We have identified deficiencies in professional knowl-
edge as an important contextual factor that can influence 
whether GPs talk about FGM. Other authors have noted 
the need for those in primary care to be informed to 
improve care for those affected by FGM.139 There is little 
evidence to support interventions to improve how HCPs 
are enabled to support their patients with FGM.151 152 
One study with 11 midwives evaluated the effectiveness 
of an educational intervention and found that it was 
successful in promoting knowledge and confidence in 
managing FGM.153 This intervention used learning from 
case studies which is suggested by community advocates 
to support FGM education.14 55 A 2016 survey of medical 
students from five medical schools in London reported 
that the majority of respondents had not received formal 
teaching on FGM and were not aware of potential associ-
ated health issues. Having had formal education increased 
awareness, but despite this, only 50% of respondents who 
had been formally educated felt confident about identi-
fying FGM on examination.154 UK medical students have 
voted to ask for education about FGM. Medical students 
reported that after attending a workshop which included 
education on FGM, the UK law and how to talk about 
FGM, 75% of them felt more confident about commu-
nicating with a patient who had had FGM.155 There is a 
call for FGM education to promote professionals’ cultural 
competency.18 29 33 156 Cultural competency education for 
HCPs offers likely benefits,157 including for patients,158 
although formal cultural competency training is often 
lacking in general practice.159 We have not identified any 
literature evaluating the impact of FGM education for 
primary care practitioners on their clinical confidence or 
cultural competencies. The need for research and evalu-
ation on interventions to support caregivers in FGM has 
been noted previously.152 A systematic review conducted 
in 2019 by three authors of this review (GH, SD and FG) 
found that, despite increases in FGM awareness in both 
healthcare and public spheres, HCPs remained subjec-
tively and objectively undereducated and underprepared 
on the issue. While isolated countries such as Sweden 
had managed to target their education effectively, the 
majority (including high prevalence nations) struggled to 
approach FGM education and training adequately. Much 
of this stemmed from issues of cultural competency and 
confidence in knowledge, as is reflected in this study.160
That it can be important for health professionals to 
manage their own emotional reactions when they are 
supporting patients affected by FGM is resonant with 
research into IPV, which tells us that clinician responses, 
including blaming, judging or pitying, should be 
avoided.95
In tabulating the available evidence relevant to our 
synthesis question, we note that the available FGM 
evidence is predominantly from obstetric settings, with a 
lack of evidence from other settings, notably primary care, 
which is an important point documented in other system-
atic reviews.17 47 The holistic life- course health needs for 
women with FGM, including their FGM- related needs 
outside of safeguarding, paediatric or obstetric settings, 
are important service and research needs.16 We also 
note that much of the identified research considers the 
needs and experience of women with type III FGM, yet an 
English specialist paediatric clinic most commonly iden-
tified type IV FGM and no cases of infibulation and iden-
tified a girl from Malaysia with FGM.75 That the existing 
evidence is potentially skewed towards type III FGM has 
been documented previously in a systematic review of 
healthcare providers experiences of caring for women 
with FGM.47 It is important that clinicians are aware of 
the practice of FGM in some Asian countries (including 
Indonesia and Malaysia), although there is little evidence 
about prevalence to guide them.75
Implications for research and practice
This review will help GPs (and GP educators) consider 
what knowledge or skills are needed to support GPs to 
feel confident to talk about FGM with their patients. It 
may help them consider the challenges when using inter-
preters to talk about FGM and highlights the potential 
challenges of managing the FGM reporting requirements.
Research is needed to explore what FGM- affected 
communities need from GPs and primary care. This 
needs to include all types of FGM, and all communities 
that practice FGM, and all aspects of access to and expe-
riences of care, whether directly related to FGM or not.
There is a need to research and understand FGM- 
related health needs throughout the life course, 
including, for example, the needs of women living with 
FGM throughout and after their menopause. Expert 
commentators have noted the lack of evidence under-
pinning some of the guidance that clinicians are offered 
about what signs they should look for to try to prevent 
or anticipate FGM.75 Clinicians urgently need evidence 
that will help them protect girls and families, including 
consideration about what policies and strategies are 
acceptable and effective within communities. We need 
evidence to inform this and believe that this needs to be 
developed in partnership with community members and 
front- line clinicians.
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The effectiveness of policies and legislation on deterring 
community practice and working towards eliminating the 
practice of FGM are vital considerations but which were 
beyond the scope of this review, which focused on their 
impacts on communication in consultation. However, 
the potential impacts of the mandatory reporting and 
FGM Enhanced Dataset requirements on healthcare 
interactions do need to be evaluated, including HCP and 
community perspectives.
Educational interventions, research and services should 
be developed in partnership with community members, 
using their expertise and experience, to ensure resources 
meet their needs.
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English general medical practitioners managing female genital mutilation in light of recent 
policy and legislative changes: A realist synthesis 
 
Sharon Dixon, Claire Duddy, Gabrielle Harrison, Chrysanthi Papoutsi, Sue Ziebland, Frances 
Griffiths. 
Prospero: CRD4201891996 
Review Question:  
1. From a realist synthesis of published literature, what influences how GPs manage 
female genital mutilation (FGM) in their clinical practice and why? 
2. What influences general medical practitioners (GPs) actions when they consider 
initiating discussion about female genital mutilation (FGM) with patients in primary 
care?  Where, when and why are these influences active?  
3.  What influences how GPs respond to a patient-initiated disclosure of FGM during a 
primary care consultation? Where, when and why are these influences active? 
  
4. Searches:  
We will use the RAMESES quality standards for realist synthesis to guide this realist review. 
We will use an information specialist to support the literature searches. 
Initial programme theory will be derived from reviewing governmental policy documents 
relevant to the management of FGM in primary care and FGM guidance from doctors’ 
professional bodies. The subsequent search strategy will be designed to identify empirical 
and theoretical literature to test the initial programme theories. The search process in a 
realist review is iterative and responsive to evolving programme theory. . The preliminary 
search will be run with keywords identified from an exploratory literature review, and will 
include FGM, primary care, and general practice/GP. e would search broadly, including using 
the following databases: Medline, Embase, PsycINFO, Global Health, Cinahl, Web of Science, 
Sociological Abstracts, Anthropology Plus, Social Science Abstracts and ASSIA, and undertake 
forward and backward citation searches to identify relevant papers  
 Subsequent literature searches will be responsive to emergent programme theory including 
potentially relevant contexts, mechanisms, and outcomes. As new theory emerges, new 
evidence needs to be considered to test this. We will purposively search and iteratively 
review evidence. All steps and decisions taken during the review will be reported and 
justified, including details about actions taken We will report review search strategies (initial 
and subsequent searches), the number of studies identified and assessed for relevance, the 
number and type of papers included and excluded and reasons for exclusion. 
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Types of study to be included: 
All study designs and theoretical papers, including conceptual papers and commentaries will 
be considered if they contribute to the development or testing of programme theory. 
Papers considering interventions in health care contexts very different to the UK healthcare 
system will be excluded. Where there is a large body of literature, we will identify 
systematic reviews in the first instance. We will include papers written in English. 
 
Condition or domain being studied: 
How GPs are managing women and families from FGM affected communities 
Participants/population: 
GPs working in the UK 
Intervention/exposure: 
Any identified factor or context that may influence  GPs’ actions and reactions in relation to 
their management of patients affected by FGM.  
 
Comparator/control:  
Contexts where an identified influence is not present 
Primary outcome: 
This realist review will result in programme theory, tested against existing evidence, on 
what influences GPs actions and reactions in relation to FGM in primary care consultations 
and, where, when and why these influences are activated. 
Timing and effect measures: 
No limitation placed on timing of influences. 




Data extraction (selection and coding): 
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Data extraction and organisation of the data will be undertaken by SD. Documents will be initially 
screened with title and abstract, and selected for inclusion for full text screening. Following full text 
screening, relevant articles will be included for coding in Nvivo. A random sample of 10% of finally 
included documents, screened abstracts, and coded full text documents will be independently 
checked by another member of the study team as a quality assurance measure. Disagreements will 
be resolved by discussion within the study team. 
The full text of included papers will be uploaded onto qualitative data analysis software tool 
(NVivo)a. We will code text sections for their relevance (or not) to each programme theory, and 
within that code context, mechanisms, and outcomes. The coding structure will be initially deductive 
derived from the initial programme theory, and also inductive, generated to categorise data in 
included papers. The processes of both coding and analysis are iterative. Through cross comparison 
of coded data, we expect to generate theory. This may suggest the need for further interrogation of 
collated evidence and so new coding and searches for new evidence.  
Risk of bias (quality) assessment: 
The study will be guided by the RAMESES quality standards for realist reviews 
(http://www.ramesesproject.org/Standards_and_Training_materials.php#qual_stand_rs) 
Papers will be appraised for relevance to the theory under test, not necessarily the topic 
under consideration, and for the rigour of the conclusions the authors drew. All included 
papers will be assessed independently by two team members. 
Strategy for data synthesis: 
Data analysis and synthesis will use a realist logic of analysis. In a realist review, the process 
of data analysis and synthesis co-exist and overlap. In realist terms, synthesis is progress 
towards explanations, which are framed as relationships between the contexts (C) in which 
outcomes under observation occur (O), and the mechanisms that potentially link these (M). 
These relationships are postulated as CMO configurations (CMOC), which are considered 
within over-arching programme theory. During analysis, we will use interpretive cross 
comparison, to understand and explain how different interventions have produced 
outcomes in different contexts and how we understand the potential mechanisms that link 
these. During CMOC development, we will review how the data supports the developing 
CMOCs, how new CMOCs relate to other postulated CMOCs and how they relate to 
programme theory being developed. The synthesis will include retroductive analysis seeking 
to identify hidden causes that can explain observed patterns in the data.  
Analysis of subgroups or subsets: 
We will potentially be testing more than one programme theory 
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GP considers 






























Refer on for specialist/further care
GP Considers/takes action on safeguarding needs of patient and her family.
GP talks about the dataset and meets their fair processing requirements
GP adds codes to medical records of woman and her family
GP considers and fulfils any required mandated actions, mandatory reporting 
and recording with the enhanced dataset
Factors that may influence at this point:
GPs familiarity with FGM, awareness of FGM including who 
may be affected (including outside stereotyped views/type 3), 
confidence in raising FGM, language access/availability of 
interpreters, GP prior of knowledge of patient, availability of 
local services, fears of offending and cultural sensitivity
Factors that may influence at this point:
GPs awareness and knowledge of FGM, availability and accessibility of local resources/specialist services, fears about 
offending/cultural sensitivity, lack of awareness that FGM is child abuse/a safeguarding concern, fear of consequences if 
does not follow rules, potential consequences of asking – includes practicalities of work generated and reporting 
requirements and ethical concerns, language barriers, experience in managing women affected by FGM and experience 
and confidence in managing requirements, recognition different types of FGM, attitude/beliefs about mandated 
reporting duties, knowledge about mandated requirements and regulations, views on cosmetic surgery, confidence 
examining female genitalia including piercings and assessing what is normal
GP shares information about FGM with other 












GP does not take action on 
learning about patients concern 
about FGM
The initial programme theory mapped onto a primary care consultation. The black boxes represent hypothesised possible outcomes and the red text and boxes 
represent potential contextual or mechanistic factors identified from an exploratory literature review and stakeholder expertise.
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Appendix C: Search strategies 
Initial scoping searches (March 2016) 
Ovid MEDLINE Search #1 
# ▲ Searches 
1 Circumcision, Female/ 
2 female genital mutilation.ti,ab. 
3 ((female? or women or girl*) adj2 circumcis*).ti,ab. 
4 ((genital? adj2 (cut or cuts or cutting)) and (female? or women or girl*)).ti,ab. 
5 1 or 2 or 3 or 4 
6 Prevalence/ 
7 *"surveys and questionnaires"/ or health care surveys/ or health surveys/ 
8 (prevalen* or burden or trend? or estimat* or survey?).ti. 
9 6 or 7 or 8 
10 5 and 9 
11 limit 10 to yr="2006 -Current" 
Ovid MEDLINE Search #2 
#▲ Searches 
1 Circumcision, Female/ 
2 female genital mutilation.ti,ab. 
3 ((female? or women or girl*) adj2 circumcis*).ti,ab. 
4 ((genital? adj2 (cut or cuts or cutting)) and (female? or women or girl*)).ti,ab. 
5 1 or 2 or 3 or 4 
6 (Qualitative systematic review* or (systematic review and qualitative)).ti,ab. 
7 (evidence synthesis or realist synthesis).ti,ab. 
8 (Qualitative and synthesis).ti,ab. 
9 (meta-synthesis* or meta synthesis* or metasynthesis).ti,ab. 
10 (meta-ethnograph* or metaethnograph* or meta ethnograph*).ti,ab. 
11 (meta-study or metastudy or meta study).ti,ab. 
12 (realist review? or realist synthesis).ti,ab. 
13 systematic review*.ti,ab. and qualitative research/ 
14 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 
BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance
Supplemental material placed on this supplemental material which has been supplied by the author(s) BMJ Open
 doi: 10.1136/bmjopen-2020-039809:e039809. 11 2021;BMJ Open, et al. Dixon S
15 5 and 14 
16 qualitative research/ 
17 *interviews as topic/ or focus groups/ or narration/ 
18 observation.ti. 
19 interview?.ti. 
20 (qualitative adj2 (interview* or study)).ti,ab. 
21 (qualitative or focus group? or story or stories or narration or narrative* or discourse or 
discursive or grounded theory or ethnogra* or phenomenolog*).ti,ab. 
22 16 or 17 or 18 or 19 or 20 or 21 
23 5 and 22 
24 15 or 23 
Global Health Search #1 
# ▲ Searches 
1 female genital mutilation.ti,ab. 
2 ((female? or women or girl*) adj2 circumcis*).ti,ab. 
3 ((genital? adj2 (cut or cuts or cutting)) and (female? or women or girl*)).ti,ab. 
4 1 or 2 or 3 
5 Prevalence/ 
6 surveys/ or household surveys/ 
7 (prevalen* or burden or trend? or estimat* or survey?).ti. 
8 5 or 6 or 7 
9 4 and 8 
10 limit 9 to yr="2006 -Current" 




1 female genital mutilation.ti,ab. 
2 ((genital? adj2 (cut or cuts or cutting)) and (female? or women or girl*)).ti,ab. 
3 ((female? or women or girl*) adj2 circumcis*).ti,ab. 
4 1 or 2 or 3 
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5 (qualitative or focus group? or story or stories or narration or narrative* or discourse or 
discursive or grounded theory or ethnogra* or phenomenolog*).ti,ab. 
6 interview*.ti,ab. 
7 5 or 6 
8 4 and 7 
Embase 
# ▲ Searches 
1 exp female genital mutilation/ 
2 female genital mutilation.ti,ab. 
3 ((female? or women or girl*) adj2 circumcis*).ti,ab. 
4 ((genital? adj2 (cut or cuts or cutting)) and (female? or women or girl*)).ti,ab. 
5 1 or 2 or 3 or 4 
6 (Qualitative systematic review* or (systematic review and qualitative)).ti,ab. 
7 (evidence synthesis or realist synthesis).ti,ab. 
8 (Qualitative and synthesis).ti,ab. 
9 (meta-synthesis* or meta synthesis* or metasynthesis).ti,ab. 
10 (meta-ethnograph* or metaethnograph* or meta ethnograph*).ti,ab. 
11 (meta-study or metastudy or meta study).ti,ab. 
12 (realist review? or realist synthesis).ti,ab. 
13 systematic review*.mp. and exp qualitative studies/ 
14 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 
15 5 and 14 
16 grounded theory/ or naturalistic inquiry/ or qualitative research/ 
17 exp *interview/ 
18 observation.ti. 
19 interview?.ti. 
20 (qualitative adj2 (interview* or study)).ti,ab. 
21 (qualitative or focus group? or story or stories or narration or narrative* or discourse 
or discursive or grounded theory or ethnogra* or phenomenolog*).ti,ab. 
22 16 or 17 or 18 or 19 or 20 or 21 
23 5 and 22 
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24 15 or 23 
PsycINFO 
# ▲ Searches 
1 circumcision/ 
2 female genital mutilation.ti,ab. 
3 ((genital? adj2 (cut or cuts or cutting)) and (female? or women or girl*)).ti,ab. 
4 ((female? or women or girl*) adj2 circumcis*).ti,ab. 
5 1 or 2 or 3 or 4 
6 (Qualitative systematic review* or (systematic review and qualitative)).ti,ab. 
7 (evidence synthesis or realist synthesis).ti,ab. 
8 (Qualitative and synthesis).ti,ab. 
9 (meta-synthesis* or meta synthesis* or metasynthesis).ti,ab. 
10 (meta-ethnograph* or metaethnograph* or meta ethnograph*).ti,ab. 
11 (meta-study or metastudy or meta study).ti,ab. 
12 (realist review? or realist synthesis).ti,ab. 
13 systematic review*.ti,ab. and qualitative research/ 
14 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 
15 5 and 14 
16 qualitative research/ or grounded theory/ or observation methods/ 
17 exp *interviews/ 
18 observation.ti. 
19 interview?.ti. 
20 (qualitative adj2 (interview* or study)).ti,ab. 
21 (qualitative or focus group? or story or stories or narration or narrative* or discourse or 
discursive 
or grounded theory or ethnogra* or phenomenolog*).ti,ab. 
22 16 or 17 or 18 or 19 or 20 or 21 
23 5 and 22 
24 15 or 23 
These search strategies were also adapted and run in 
• ASSIA, 
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• Sociological Abstracts 
• CINAHL 
• Anthropology Plus 
• Web of Science (Core Collection databases) 
A total of 1554 references were screened by title and abstract, 181 were read in full text and 22 
contributed to the synthesis. 
Main FGM searches (August 2017) 
Summary of searching and results 




Ovid MEDLINE(R) Epub 
Ahead of Print, In-Process & 
Other Non-Indexed 
Citations, Ovid MEDLINE(R) 
Daily and Ovid MEDLINE(R) 
OvidSp 1946-present 22/08/2017 21 384 
Embase OvidSp 1974 to 2017 
August 21 
22/08/2017 31 396 
PsycINFO OvidSp 1967 to August 
Week 2 2017 
22/08/2017 0 57 
CINAHL EBSCOHost 1982-present 22/08/2017 16 575 




1945-present 22/08/2017 0 280 
Nexis UK Lexis Nexis 22/08/2017 0 260 
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Proquest Social Science 
Databases 





1 Circumcision, Female/ 
2 (femal genital mutilation or fgm).ti,ab. 
3 ((genital? adj2 (cut or cuts or cutting)) and (female? or women or girls)).ti,ab. 
4 ((female? or women or girl*) adj2 circumcis*).ti,ab. 
5 1 or 2 or 3 or 4 
6 exp General Practice/ 
7 general practitioners/ or physicians, family/ or physicians, primary care/ 
8 Primary Health Care/ 
9 (((general or family) adj2 (practi* or physician? or doctor?)) or gp or gps).ti,ab. 
10 (doctor? or physician?).ti. 
11 (primary adj2 (care or healthcare)).ti,ab. 
12 6 or 7 or 8 or 9 or 10 or 11 
13 exp United Kingdom/ 
14 (united kingdom or uk or britain or gb or england or wales or scotland or northern 
ireland).ti,ab,in. 
15 (nhs or national health service).ti,ab,in. 
16 (british or bjgp or bmj or hsj or pulse or gp or general practi* or primary care or nursing standard 
or nursing times).jw. 
17 13 or 14 or 15 or 16 
18 5 and 12 and 17 
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Searches 
1 female genital mutilation/ 
2 (femal genital mutilation or fgm).ti,ab. 
3 ((genital? adj2 (cut or cuts or cutting)) and (female? or women or girls)).ti,ab. 
4 ((female? or women or girl*) adj2 circumcis*).ti,ab. 
5 1 or 2 or 3 or 4 
6 General Practice/ 
7 general practitioner/ 
8 Primary Medical Care/ 
9 (((general or family) adj2 (practi* or physician? or doctor?)) or gp or gps).ti,ab. 
10 (doctor? or physician?).ti. 
11 (primary adj2 (care or healthcare)).ti,ab. 
12 6 or 7 or 8 or 9 or 10 or 11 
13 exp United Kingdom/ 
14 (united kingdom or uk or britain or gb or england or wales or scotland or northern 
ireland).ti,ab,in. 
15 (nhs or national health service).ti,ab,in. 
16 (british or bjgp or bmj or hsj or pulse or gp or general practi* or primary care or nursing 
standard or nursing times).jw. 
17 13 or 14 or 15 or 16 
18 5 and 12 and 17 





1 (exp Human Females/ or exp Female Genitalia/) and exp Circumcision/ 
2 (femal genital mutilation or fgm).ti,ab. 
3 ((genital? adj2 (cut or cuts or cutting)) and (female? or women or girls)).ti,ab. 
4 ((female? or women or girl*) adj2 circumcis*).ti,ab. 
5 1 or 2 or 3 or 4 
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6 general practitioners/ 
7 Primary Health Care/ 
8 (((general or family) adj2 (practi* or physician? or doctor?)) or gp or gps).ti,ab. 
9 (doctor? or physician?).ti. 
10 (primary adj2 (care or healthcare)).ti,ab. 
11 6 or 7 or 8 or 9 or 10 
12 (united kingdom or uk or britain or gb or england or wales or scotland or northern 
ireland).ti,ab,in. 
13 (nhs or national health service).ti,ab,in. 
14 (british or bjgp or bmj or hsj or pulse or gp or general practi* or primary care or nursing 
standard or nursing times).jw. 
15 12 or 13 or 14 
16 5 and 11 and 15 
17 5 and 15 
CINAHL 
# Query 
S19 S5 AND S17 
S18 S5 AND S12 AND S17 
S17 S13 OR S14 OR S15 OR S16 
S16 SO british or bjgp or bmj or hsj or pulse or gp or general practi* or primary care or nursing 
standard or nursing times) 
S15 TX nhs or "national health service" 
S14 TX "united kingdom" or uk or britain or gb or england or wales or scotland or "northern ireland" 
S13 (MH "United Kingdom+") 
S12 S6 OR S7 OR S8 OR S9 OR S10 OR S11 
S11 TI ( (primary N2 (care or healthcare)) ) OR AB ( (primary N2 (care or healthcare)) ) 
S10 TI doctor? or physician? 
S9 TI ( (((general or family) N2 (practi* or physician? or doctor?)) or gp or gps) ) OR AB ( (((general or 
family) N2 (practi* or physician? or doctor?)) or gp or gps) ) 
S8 (MH "Primary Health Care") 
S7 (MH "Physicians, Family") 
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S6 (MH "Family Practice") 
S5 S1 OR S2 OR S3 OR S4 
S4 TI ( ((female? or women or girl*) N2 circumcis*) ) OR AB ( ((female? or women or girl*) N2 
circumcis*) ) 
S3 TI ( ((genital? N2 (cut or cuts or cutting)) and (female? or women or girls)) ) OR AB ( ((genital? N2 
(cut or cuts or cutting)) and (female? or women or girls)) ) 
S2 TI ( "femal genital mutilation" or fgm ) OR AB ( "femal genital mutilation" or fgm ) 
S1 (MH "Circumcision, Female") 
Web of Science (Core Collection) 
Set Results 
# 5 280 #3 AND #1 
# 4 0 #3 AND #2 AND #1 
# 3 5,132,695 TOPIC: ("united kingdom" or uk or britain or gb or england or wales or scotland or 
"northern ireland") OR ADDRESS: ("united kingdom" or uk or britain or gb or england 
or wales or scotland or "northern ireland") OR TOPIC: (nhs or "national health 
service") OR ADDRESS: (nhs or "national health service") OR PUBLICATION NAME: 
(british or bjgp or bmj or hsj or pulse or gp or general practi* or primary care or 
nursing standard or nursing times) 
# 2 339,275 TOPIC: ((((general or family) NEAR/2 (practi* or physician? or doctor?)) or gp or gps)) 
OR TITLE: (doctor? or physician?) OR TOPIC: ((primary NEAR/2 (care or healthcare))) 
# 1 5,251 TOPIC: ("femal genital mutilation" or fgm) OR TOPIC: (((genital? NEAR/2 (cut or cuts 
or cutting)) and (female? or women or girls))) OR TOPIC: (((female? or women or 
girl*) NEAR/2 circumcis*)) 
Nexis UK 
fgm OR "female genital mutilation" In the Headline 
gp OR gps OR general practitioners OR doctors Anywhere in the text 
Limits 
Previous 2 year 
UK publications 
Proquest Social Science Databases 
Set Search 
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S7 S3 AND S5 
S6 S3 AND S4 AND S5 
S5 all("united kingdom" or uk or britain or gb or england or wales or scotland or 
"northern ireland") OR all(nhs OR "national health service") 
S4 all(((general or family) NEAR/2 (practi* or physician or doctor)) or gp or gps) OR 
ti(doctor OR physician) OR all("primary care" OR "primary healthcare" OR "primary 
health care") 
S3 all("femal genital mutilation" or fgm) OR all((((genital? NEAR/2 (cut or cuts or 
cutting)) and (female? or women or girls)))) OR all((((female? or women or girl*) 
NEAR/2 circumcis*))) 
A total of 2052 references were screened by title and abstract, 73 were read in full text. 
Website searches 
In addition to these searches, a search of relevant advocacy organisation websites was undertaken, 
including searching: 
• Sharon add a list of links to relevant organisation homepages here – just illustrative not 
everything, say, maybe 5? 
Update searches (July 2018, April 2019) 
Summary of searching and results (July 2018) 




Ovid MEDLINE(R) Epub 
Ahead of Print, In-Process & 
Other Non-Indexed 
Citations, Ovid MEDLINE(R) 
Daily and Ovid MEDLINE(R) 
OvidSp 1946-present 22/08/2017 21 384 
Embase OvidSp 1974 to 2017 
August 21 
22/08/2017 31 396 
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PsycINFO OvidSp 1967 to August 
Week 2 2017 
22/08/2017 0 57 
CINAHL EBSCOHost 1982-present 22/08/2017 16 575 




1945-present 22/08/2017 0 280 
Nexis UK Lexis Nexis 22/08/2017 0 260 
Proquest Social Science 
Databases 
Proquest 22/08/2017 5 100 
Update searches in July 2018 replicated the Main FGM searches shown above, limited to results 
added to databases from August 2017 onwards. 
Summary of searching and results (April 2019) 






Ovid MEDLINE(R) Epub 
Ahead of Print, In-Process 
& Other Non-Indexed 
Citations, Ovid 
MEDLINE(R) Daily and 
Ovid MEDLINE(R) 
OvidSp 1946-present 23/04/2019 2 7 
Embase OvidSp 1974 to 2017 
August 21 
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23/04/2019 1 31 
PsycINFO OvidSp 1967 to August 
Week 2 2017 
23/04/2019 0 0 
CINAHL EBSCOHost 1982-present 23/04/2019 3 10 




1945-present 23/04/2019 7 Not 
searched 
Nexis UK Lexis Nexis 23/04/2019 90 Not 
searched 
Proquest Social Science 
Databases 
Proquest 23/04/2019 3 48 
Update searches in April 2019 replicated the Main FGM searches shown above, limited to results 
added to databases from July 2018 onwards. For pragmatic reasons, WoS Core Collection and Nexis 
UK were only searched for terms relating to GPs/primary care and not other health professional 
groups. 
A total of 429 new references were identified in the update searches and screened by title and 
abstract, 92 were read in full text. 
Supplementary searches (Various dates) 
Summary of searching and results: DVLA, IPV/DVA and Prevent searches (August 2017) 
Database Interface Coverage Date DVLA IPV Prevent 
Ovid MEDLINE(R) Epub 
Ahead of Print, InProcess & Other NonIndexed Citations, Ovid 
MEDLINE(R) Daily and 
Ovid MEDLINE(R) 
OvidSp 1946-present 22/08/2017 52 142 7 
Embase OvidSp 1974 to 2017 
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August 21 
22/08/2017 137 244 9 
PsycINFO OvidSp 1967 to August 
Week 2 2017 
22/08/2017 8 69 1 
CINAHL EBSCOHost 1982-present 22/08/2017 53 399 69 




1945-present 22/08/2017 74 150 14 
Proquest Social Science 
Databases 
Proquest 22/08/2017 10 57 16 
Summary of searching and results: Mandatory reporting search (May 2018) 
Database Interface Coverage Date Results 
PubMed PubMed 1946-present May 2018 




1945-present May 2018 





1 ("driver and vehicle licensing agency" or dvla).ti,ab. 
2 ((driving or driver?) adj5 (notif* or report* or inform*)).ti,ab. 
3 ((driving or driver?) adj5 (ability or competen* or incompeten* or status or continu* 
or discontinu* or stop* or quit* or cease* or cessation)).ti,ab. 
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4 ((driving or driver?) adj3 (licens* or law* or legal*)).ti,ab. 
5 (driv* adj3 (fit or fitness)).ti,ab. 
6 Licensure/ and Automobile Driving/ 
7 1 or 2 or 3 or 4 or 5 or 6 
8 exp General Practice/ 
9 general practitioners/ or physicians, family/ or physicians, primary care/ 
10 Primary Health Care/ 
11 (((general or family) adj2 (practi* or physician? or doctor?)) or gp or gps).ti,ab. 
12 (doctor? or physician?).ti. 
13 (primary adj2 (care or healthcare)).ti,ab. 
14 8 or 9 or 10 or 11 or 12 or 13 
15 exp United Kingdom/ 
16 (united kingdom or uk or britain or gb or england or wales or scotland or northern 
ireland).ti,ab,in. 
17 (nhs or national health service).ti,ab,in. 
18 (british or bjgp or bmj or hsj or pulse or gp or general practi* or primary care or 
nursing standard or nursing times).jw. 
19 15 or 16 or 17 or 18 





1 ("driver and vehicle licensing agency" or dvla).ti,ab. 
2 ((driving or driver?) adj5 (notif* or report* or inform*)).ti,ab. 
3 ((driving or driver?) adj5 (ability or competen* or incompeten* or status or continu* or 
discontinu* or stop* or quit* or cease* or cessation)).ti,ab. 
4 ((driving or driver?) adj3 (licens* or law* or legal*)).ti,ab. 
5 (driv* adj3 (fit or fitness)).ti,ab. 
6 driving ability/ or driver licence/ 
7 1 or 2 or 3 or 4 or 5 or 6 
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8 General Practice/ 
9 general practitioner/ 
10 Primary Medical Care/ 
11 (((general or family) adj2 (practi* or physician? or doctor?)) or gp or gps).ti,ab. 
12 (doctor? or physician?).ti. 
13 (primary adj2 (care or healthcare)).ti,ab. 
14 8 or 9 or 10 or 11 or 12 or 13 
15 exp United Kingdom/ 
16 (united kingdom or uk or britain or gb or england or wales or scotland or northern 
ireland).ti,ab,in. 
17 (nhs or national health service).ti,ab,in. 
18 (british or bjgp or bmj or hsj or pulse or gp or general practi* or primary care or nursing 
standard or nursing times).jw. 
19 15 or 16 or 17 or 18 
20 7 and 14 and 19 
PsycINFO 
# ▲ Searches 
1 ("driver and vehicle licensing agency" or dvla).ti,ab. 
2 ((driving or driver?) adj5 (notif* or report* or inform*)).ti,ab. 
3 ((driving or driver?) adj5 (ability or competen* or incompeten* or status or 
continu* or discontinu* or stop* or quit* or cease* or cessation)).ti,ab. 
4 ((driving or driver?) adj3 (licens* or law* or legal*)).ti,ab. 
5 (driv* adj3 (fit or fitness)).ti,ab. 
6 1 or 2 or 3 or 4 or 5 
7 general practitioners/ 
8 Primary Health Care/ 
9 (((general or family) adj2 (practi* or physician? or doctor?)) or gp or gps).ti,ab. 
10 (doctor? or physician?).ti. 
11 (primary adj2 (care or healthcare)).ti,ab. 
12 7 or 8 or 9 or 10 or 11 
13 (united kingdom or uk or britain or gb or england or wales or scotland or northern 
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ireland).ti,ab,in. 
14 (nhs or national health service).ti,ab,in. 
15 (british or bjgp or bmj or hsj or pulse or gp or general practi* or primary care or 
nursing standard or nursing times).jw. 
16 13 or 14 or 15 
17 6 and 12 and 16 
CINAHL 
S6 S3 AND S4 AND S5 
S5 ( ((driving or driver?) N5 (notif* or report* or inform*)) ) OR ( ((driving or driver?) N5 (ability 
or competen* or incompeten* or status or continu* or discontinu* or stop* or quit* or 
cease* or cessation)) ) OR ( ((driving or driver?) N3 (licens* or law* or legal*)) ) OR ( (driv* N3 
(fit or fitness)) ) OR ( "driver and vehicle licensing agency" or dvla ) 
S4 (MH "United Kingdom+") OR ( AB "united kingdom" or uk or britain or gb or england or wales 
or scotland or "northern ireland" ) OR ( AB nhs or "national health service" ) OR ( SO british or 
bjgp or bmj or hsj or pulse or gp or general practi* or primary care or nursing standard or 
nursing times ) OR ( TI "united kingdom" or uk or britain or gb or england or wales or scotland 
or "northern ireland" ) OR ( TI nhs or "national health service" ) 
S3 S1 OR S2 
S2 TI ( (((general or family) N2 (practi* or physician? or doctor?)) or gp or gps) ) OR AB ( 
(((general or family) N2 (practi* or physician? or doctor?)) or gp or gps) ) OR TI ( doctor? or 
physician? ) OR TI ( (primary N2 (care or healthcare)) ) OR AB ( (primary N2 (care or 
healthcare)) ) 
S1 (MH "Family Practice") OR (MH "Physicians, Family") OR (MH "Primary Health Care") 
Web of Science (Core Collection) 
# 
4 
74 #3 AND #2 AND #1 
# 
3 
36,160 TS=("driver and vehicle licensing agency" or dvla) OR TS=(((driving or driver?) 
NEAR/5 (notif* or report* or inform*))) OR TS=(((driving or driver?) NEAR/5 
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(ability or competen* or incompeten* or status or continu* or discontinu* or 
stop* or quit* or cease* or cessation))) OR TS=(((driving or driver?) NEAR/3 
(licens* or law* or legal*))) OR TS=((driv* NEAR/3 (fit or fitness))) 
# 
2 
5,132,695 TS=("united kingdom" or uk or britain or gb or england or wales or scotland or 
"northern ireland") OR ADDRESS: ("united kingdom" or uk or britain or gb or 
england or wales or scotland or "northern ireland") OR TS=(nhs or "national 
health service") OR ADDRESS: (nhs or "national health service") OR 
PUBLICATION NAME: (british or bjgp or bmj or hsj or pulse or gp or general 
practi* or primary care or nursing standard or nursing times) 
# 
1 
339,275 TS=((((general or family) NEAR/2 (practi* or physician? or doctor?)) or gp or 
gps)) OR TI=(doctor? or physician?) OR TS=((primary NEAR/2 (care or 
healthcare))) 
Proquest Social Science Databases 
S6 S1 AND S2 AND S5 
S5 all("driver and vehicle licensing agency" OR dvla) OR all((driving OR driver) NEAR/5 (notif* 
OR report* OR inform*)) OR all(((driving OR driver) NEAR/5 (ability OR competen* OR 
incompeten* OR status OR continu* OR discontinu* OR stop* OR quit* OR cease* OR 
cessation))) OR all(((driving OR driver) NEAR/3 (licens* OR law* OR legal*))) OR all((driv* 
NEAR/3 (fit OR fitness))) 
S2 all(((general or family) NEAR/2 (practi* or physician or doctor)) or gp or gps) OR ti(doctor 
OR physician) OR all("primary care" OR "primary healthcare" OR "primary health care") 
S1 all("united kingdom" or uk or britain or gb or england or wales or scotland or "northern 
ireland") OR all(nhs OR "national health service") 
A total of 131 citations were screened by title and abstract, 6 were screened in full text and none 
were included in the final synthesis. 
Prevent (August 2017) 
MEDLINE 
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# 
▲ Searches 
1 (prevent adj (program* or strateg* or initiative or policy)).ti,ab. 
2 
(prevent* and (terroris* or counterterroris* or antiterroris* or extremis* or counterextremis* or 
antiextremis* or radicali* or counterradicali* or antiradicali*)).ti. 
3 
(prevent* adj5 (terroris* or counterterroris* or antiterroris* or extremis* or counterextremis* 
or antiextremis* or radicali* or counterradicali* or antiradicali*)).ti,ab. 
4 1 or 2 or 3 
5 exp General Practice/ 
6 general practitioners/ or physicians, family/ or physicians, primary care/ 
7 Primary Health Care/ 
8 (((general or family) adj2 (practi* or physician? or doctor?)) or gp or gps).ti,ab. 
9 (doctor? or physician?).ti. 
10 (primary adj2 (care or healthcare)).ti,ab. 
11 5 or 6 or 7 or 8 or 9 or 10 
12 exp United Kingdom/ 
13 
(united kingdom or uk or britain or gb or england or wales or scotland or northern 
ireland).ti,ab,in. 
14 (nhs or national health service).ti,ab,in. 
15 
(british or bjgp or bmj or hsj or pulse or gp or general practi* or primary care or nursing standard 
or nursing times).jw. 
16 12 or 13 or 14 or 15 




1 (prevent adj (program* or strateg* or initiative or policy)).ti,ab. 
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2 
(prevent* and (terroris* or counterterroris* or antiterroris* or extremis* or counterextremis* or 
antiextremis* or radicali* or counterradicali* or antiradicali*)).ti. 
3 
(prevent* adj5 (terroris* or counterterroris* or antiterroris* or extremis* or counterextremis* or 
antiextremis* or radicali* or counterradicali* or antiradicali*)).ti,ab. 
4 1 or 2 or 3 
5 General Practice/ 
6 general practitioner/ 
7 Primary Medical Care/ 
8 (((general or family) adj2 (practi* or physician? or doctor?)) or gp or gps).ti,ab. 
9 (doctor? or physician?).ti. 
10 (primary adj2 (care or healthcare)).ti,ab. 
11 5 or 6 or 7 or 8 or 9 or 10 
12 exp United Kingdom/ 
13 
(united kingdom or uk or britain or gb or england or wales or scotland or northern 
ireland).ti,ab,in. 
14 (nhs or national health service).ti,ab,in. 
15 
(british or bjgp or bmj or hsj or pulse or gp or general practi* or primary care or nursing standard 
or nursing times).jw. 
16 12 or 13 or 14 or 15 
17 4 and 11 and 16 
PsycINFO 
▲ Searches 
1 (prevent adj (program* or strateg* or initiative or policy)).ti,ab. 
2 
(prevent* and (terroris* or counterterroris* or antiterroris* or extremis* or counterextremis* or 
antiextremis* or radicali* or counterradicali* or antiradicali*)).ti. 
3 
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(prevent* adj5 (terroris* or counterterroris* or antiterroris* or extremis* or counterextremis* or 
antiextremis* or radicali* or counterradicali* or antiradicali*)).ti,ab. 
4 1 or 2 or 3 
5 general practitioners/ 
6 Primary Health Care/ 
7 (((general or family) adj2 (practi* or physician? or doctor?)) or gp or gps).ti,ab. 
8 (doctor? or physician?).ti. 
9 (primary adj2 (care or healthcare)).ti,ab. 
10 5 or 6 or 7 or 8 or 9 
11 
(united kingdom or uk or britain or gb or england or wales or scotland or northern 
ireland).ti,ab,in. 
12 (nhs or national health service).ti,ab,in. 
13 
(british or bjgp or bmj or hsj or pulse or gp or general practi* or primary care or nursing standard 
or nursing times).jw. 
14 11 or 12 or 13 
15 4 and 10 and 14 
CINAHL 
S12 S3 AND S4 AND S11 
S11 AB ( (prevent N1 (program* or strateg* or initiative or policy)) ) OR TI ( (prevent* and (terroris* 
or counterterroris* or antiterroris* or extremis* or counterextremis* or antiextremis* or 
radicali* or counterradicali* or antiradicali*)) ) OR AB ( (prevent* N5 (terroris* or 
counterterroris* or antiterroris* or extremis* or counterextremis* or antiextremis* or radicali* 
or counterradicali* or antiradicali*)) ) 
S4 (MH "United Kingdom+") OR ( AB "united kingdom" or uk or britain or gb or england or wales or 
scotland or "northern ireland" ) OR ( AB nhs or "national health service" ) OR ( SO british or bjgp 
or bmj or hsj or pulse or gp or general practi* or primary care or nursing standard or nursing 
times ) OR ( TI "united kingdom" or uk or britain or gb or england or wales or scotland or 
"northern ireland" ) OR ( TI nhs or "national health service" ) 
S3 S1 OR S2 
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S2 TI ( (((general or family) N2 (practi* or physician? or doctor?)) or gp or gps) ) OR AB ( (((general or 
family) N2 (practi* or physician? or doctor?)) or gp or gps) ) OR TI ( doctor? or physician? ) OR TI ( 
(primary N2 (care or healthcare)) ) OR AB ( (primary N2 (care or healthcare)) ) 
S1 (MH "Family Practice") OR (MH "Physicians, Family") OR (MH "Primary Health Care") 
Web of Science (Core Collection) 
# 8 14 #7 AND #2 AND #1 
# 7 2,755 TS=((prevent NEXT (program* or strateg* or initiative or policy))) OR TI=((prevent* and 
(terroris* or counterterroris* or antiterroris* or extremis* or counterextremis* or 
antiextremis* or radicali* or counterradicali* or antiradicali*))) OR TS=((prevent* 
NEAR/5 (terroris* or counterterroris* or antiterroris* or extremis* or counterextremis* 
or antiextremis* or radicali* or counterradicali* or antiradicali*))) 
# 2 5,132,695 TS=("united kingdom" or uk or britain or gb or england or wales or scotland or 
"northern ireland") OR ADDRESS: ("united kingdom" or uk or britain or gb or england or 
wales or scotland or "northern ireland") OR TS=(nhs or "national health service") OR 
ADDRESS: (nhs or "national health service") OR PUBLICATION NAME: (british or bjgp or 
bmj or hsj or pulse or gp or general practi* or primary care or nursing standard or 
nursing times) 
# 1 339,275 TS=((((general or family) NEAR/2 (practi* or physician? or doctor?)) or gp or gps)) OR 
TI=(doctor? or physician?) OR TS=((primary NEAR/2 (care or healthcare))) 
Proquest Social Science Databases 
Set Search 
S11 S1 AND S2 AND S10 
S10 all((prevent NEXT (program* OR strateg* OR initiative OR policy))) OR ti((prevent* AND 
(terroris* OR counterterroris* OR antiterroris* OR extremis* OR counterextremis* OR 
antiextremis* OR radicali* OR counterradicali* OR antiradicali*))) OR all((prevent* 
NEAR/5 (terroris* OR counterterroris* OR antiterroris* OR extremis* OR 
counterextremis* OR antiextremis* OR radicali* OR counterradicali* OR antiradicali*))) 
S2 all(((general or family) NEAR/2 (practi* or physician or doctor)) or gp or gps) OR ti(doctor 
OR physician) OR all("primary care" OR "primary healthcare" OR "primary health care") 
S1 all("united kingdom" or uk or britain or gb or england or wales or scotland or "northern 
ireland") OR all(nhs OR "national health service") 
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A total of 22 citations were screened by title and abstract, 17 were screened in full text and 5 were 
included in the final synthesis. 
IPV/DVA (August 2017) 
MEDLINE 
# ▲ Searches 
1 domestic violence/ or spouse abuse/ 
2 ((domestic or spous* or partner? or wife or wives or husband) adj2 (violence or abuse*)).ti,ab. 
3 (batter* adj2 (spous* or partner? or wife or wives or husband)).ti,ab. 
4 1 or 2 or 3 
5 exp General Practice/ 
6 general practitioners/ or physicians, family/ or physicians, primary care/ 
7 Primary Health Care/ 
8 (((general or family) adj2 (practi* or physician? or doctor?)) or gp or gps).ti,ab. 
9 (doctor? or physician?).ti. 
10 (primary adj2 (care or healthcare)).ti,ab. 
11 5 or 6 or 7 or 8 or 9 or 10 
12 exp United Kingdom/ 
13 
(united kingdom or uk or britain or gb or england or wales or scotland or northern 
ireland).ti,ab,in. 
14 (nhs or national health service).ti,ab,in. 
15 
(british or bjgp or bmj or hsj or pulse or gp or general practi* or primary care or nursing 
standard or nursing times).jw. 
16 12 or 13 or 14 or 15 
17 4 and 11 and 16 
Embase 
▲ Searches 
1 domestic violence/ or battered woman/ or family violence/ or exp partner violence/ 
2 ((domestic or spous* or partner? or wife or wives or husband) adj2 (violence or abuse*)).ti,ab. 
3 (batter* adj2 (spous* or partner? or wife or wives or husband)).ti,ab. 
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4 1 or 2 or 3 
5 General Practice/ 
6 general practitioner/ 
7 Primary Medical Care/ 
8 (((general or family) adj2 (practi* or physician? or doctor?)) or gp or gps).ti,ab. 
9 (doctor? or physician?).ti. 
10 (primary adj2 (care or healthcare)).ti,ab. 
11 5 or 6 or 7 or 8 or 9 or 10 
12 exp United Kingdom/ 
13 
(united kingdom or uk or britain or gb or england or wales or scotland or northern 
ireland).ti,ab,in. 
14 (nhs or national health service).ti,ab,in. 
15 
(british or bjgp or bmj or hsj or pulse or gp or general practi* or primary care or nursing 
standard or nursing times).jw. 
16 12 or 13 or 14 or 15 
17 4 and 11 and 16 
PsycINFO 
▲ Searches 
1 domestic violence/ or battered females/ or intimate partner violence/ or exp partner abuse/ 
2 ((domestic or spous* or partner? or wife or wives or husband) adj2 (violence or abuse*)).ti,ab. 
3 (batter* adj2 (spous* or partner? or wife or wives or husband)).ti,ab. 
4 1 or 2 or 3 
5 general practitioners/ 
6 Primary Health Care/ 
7 (((general or family) adj2 (practi* or physician? or doctor?)) or gp or gps).ti,ab. 
8 (doctor? or physician?).ti. 
9 (primary adj2 (care or healthcare)).ti,ab. 
10 5 or 6 or 7 or 8 or 9 
11 
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(united kingdom or uk or britain or gb or england or wales or scotland or northern 
ireland).ti,ab,in. 
12 (nhs or national health service).ti,ab,in. 
13 
(british or bjgp or bmj or hsj or pulse or gp or general practi* or primary care or nursing 
standard or nursing times).jw. 
14 11 or 12 or 13 
15 4 and 10 and 14 
CINAHL 
S10 S3 AND S4 AND S9 
S9 S7 OR S8 
S8 AB ( ((domestic or spous* or partner? or wife or wives or husband) N2 (violence or abuse*)) ) OR 
AB ( (batter* N2 (spous* or partner? or wife or wives or husband)) ) OR TI ( ((domestic or spous* 
or partner? or wife or wives or husband) N2 (violence or abuse*)) ) OR TI ( (batter* N2 (spous* or 
partner? or wife or wives or husband)) ) 
S7 (MH "Domestic Violence") OR (MH "Intimate Partner Violence") 
S4 (MH "United Kingdom+") OR ( AB "united kingdom" or uk or britain or gb or england or wales or 
scotland or "northern ireland" ) OR ( AB nhs or "national health service" ) OR ( SO british or bjgp 
or bmj or hsj or pulse or gp or general practi* or primary care or nursing standard or nursing 
times ) OR ( TI "united kingdom" or uk or britain or gb or england or wales or scotland or 
"northern ireland" ) OR ( TI nhs or "national health service" ) 
S3 S1 OR S2 
S2 TI ( (((general or family) N2 (practi* or physician? or doctor?)) or gp or gps) ) OR AB ( (((general or 
family) N2 (practi* or physician? or doctor?)) or gp or gps) ) OR TI ( doctor? or physician? ) OR TI ( 
(primary N2 (care or healthcare)) ) OR AB ( (primary N2 (care or healthcare)) ) 
S1 (MH "Family Practice") OR (MH "Physicians, Family") OR (MH "Primary Health Care") 
Web of Science (Core Collection) 
# 6 150 #5 AND #2 AND #1 
# 5 15,568 TS=(((domestic or spous* or partner? or wife or wives or husband) NEAR/2 (violence or 
abuse*))) OR TS=((batter* NEAR/2 (spous* or partner? or wife or wives or husband))) 
# 2 5,132,695 TS=("united kingdom" or uk or britain or gb or england or wales or scotland or 
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"northern ireland") OR ADDRESS: ("united kingdom" or uk or britain or gb or england or 
wales or scotland or "northern ireland") OR TS=(nhs or "national health service") OR 
ADDRESS: (nhs or "national health service") OR PUBLICATION NAME: (british or bjgp or 
bmj or hsj or pulse or gp or general practi* or primary care or nursing standard or 
nursing times) 
# 1 339,275 TS=((((general or family) NEAR/2 (practi* or physician? or doctor?)) or gp or gps)) OR 
TI=(doctor? or physician?) OR TS=((primary NEAR/2 (care or healthcare))) 
Proquest Social Science Databases 
S8 S1 AND S2 AND S7 
S7 all(((domestic or spous* or partner? or wife or wives or husband) NEAR/2 (violence or 
abuse*))) OR all((batter* NEAR/2 (spous* or partner? or wife or wives or husband))) 
S2 all(((general or family) NEAR/2 (practi* or physician or doctor)) or gp or gps) OR ti(doctor 
OR physician) OR all("primary care" OR "primary healthcare" OR "primary health care") 
S1 all("united kingdom" or uk or britain or gb or england or wales or scotland or "northern 
ireland") OR all(nhs OR "national health service") 
A total of 352 citations were screened by title and abstract, 62 were screened in full text and 15 




#29 Select 6 document(s) Filters: published in the last 10 years; English 
#28 Search (((((relig* OR muslim* OR islam* or "far right") AND (extremis* OR terror* 
or radicalisation OR radicalization)) OR (((relig* OR muslim* OR islam* or "far right" 
OR extremis* OR terror* or radicalisation OR radicalization) AND ((prevent 
strateg*[Title/Abstract]) OR prevent program*[Title/Abstract])))) AND "last 10 
years"[PDat] AND English[lang])) AND ((uk OR "united kingdom" OR gb OR britian 
OR england OR wales OR scotland OR "northern ireland" OR nhs OR british) AND 
"last 10 years"[PDat] AND English[lang]) Filters: published in the last 10 years; 
English 
#27 Search uk OR "united kingdom" OR gb OR britian OR england OR wales OR scotland 
OR "northern ireland" OR nhs OR british Filters: published in the last 10 years; 
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English 
#26 Search ((relig* OR muslim* OR islam* or "far right") AND (extremis* OR terror* or 
radicalisation OR radicalization)) OR (((relig* OR muslim* OR islam* or "far right" 
OR extremis* OR terror* or radicalisation OR radicalization) AND ((prevent 
strateg*[Title/Abstract]) OR prevent program*[Title/Abstract]))) Filters: published 
in the last 10 years; English 
#24 Search (((((relig* OR muslim* OR islam* or "far right") AND (extremis* OR terror* 
or radicalisation OR radicalization))) AND ("last 10 years"[PDat] AND English[lang] 
AND (infant[MeSH] OR child[MeSH] OR adolescent[MeSH])))) OR (((((relig* OR 
muslim* OR islam* or "far right" OR extremis* OR terror* or radicalisation OR 
radicalization) AND ("last 10 years"[PDat] AND English[lang] AND (infant[MeSH] OR 
child[MeSH] OR adolescent[MeSH])))) AND (((prevent strateg*[Title/Abstract]) OR 
prevent program*[Title/Abstract]) AND ("last 10 years"[PDat] AND English[lang] 
AND (infant[MeSH] OR child[MeSH] OR adolescent[MeSH])))) AND ("last 10 
years"[PDat] AND English[lang] AND (infant[MeSH] OR child[MeSH] OR 
adolescent[MeSH]))) Filters: published in the last 10 years; English 
#23 Search (((((relig* OR muslim* OR islam* or "far right") AND (extremis* OR terror* 
or radicalisation OR radicalization))) AND ("last 10 years"[PDat] AND English[lang] 
AND (infant[MeSH] OR child[MeSH] OR adolescent[MeSH])))) OR (((((relig* OR 
muslim* OR islam* or "far right" OR extremis* OR terror* or radicalisation OR 
radicalization) AND ("last 10 years"[PDat] AND English[lang] AND (infant[MeSH] OR 
child[MeSH] OR adolescent[MeSH])))) AND (((prevent strateg*[Title/Abstract]) OR 
prevent program*[Title/Abstract]) AND ("last 10 years"[PDat] AND English[lang] 
AND (infant[MeSH] OR child[MeSH] OR adolescent[MeSH])))) AND ("last 10 
years"[PDat] AND English[lang] AND (infant[MeSH] OR child[MeSH] OR 
adolescent[MeSH]))) Filters: published in the last 10 years; English; Child: birth-18 
years 
#22 Search (((relig* OR muslim* OR islam* or "far right" OR extremis* OR terror* or 
radicalisation OR radicalization) AND ("last 10 years"[PDat] AND English[lang] AND 
(infant[MeSH] OR child[MeSH] OR adolescent[MeSH])))) AND (((prevent 
strateg*[Title/Abstract]) OR prevent program*[Title/Abstract]) AND ("last 10 
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years"[PDat] AND English[lang] AND (infant[MeSH] OR child[MeSH] OR 
adolescent[MeSH]))) Filters: published in the last 10 years; English; Child: birth-18 
years 
#21 Search relig* OR muslim* OR islam* or "far right" OR extremis* OR terror* or 
radicalisation OR radicalization Filters: published in the last 10 years; English; Child: 
birth-18 years 
#20 Search (prevent strateg*[Title/Abstract]) OR prevent program*[Title/Abstract] 
Filters: published in the last 10 years; English; Child: birth-18 years 
#19 Search ((relig* OR muslim* OR islam* or "far right") AND (extremis* OR terror* or 
radicalisation OR radicalization)) Filters: published in the last 10 years; English; 
Child: birth-18 years 
#15 Search "moral imperative" OR "ethical imperative" OR "emotional imperative" 
Filters: published in the last 10 years; English; Child: birth-18 years 
#14 Search "moral imperative" OR "ethical imperative" OR "emotional imperative" 
Filters: published in the last 10 years; Child: birth-18 years 
#13 Search "moral imperative" OR "ethical imperative" OR "emotional imperative" 
Filters: Child: birth-18 years 
#12 Search ((mandatory report*[tiab] OR mandated report*[tiab] OR mandatory 
notif*[tiab] OR mandated notif*[tiab])) OR (mandat*[ti] AND (report*[ti] OR 
notif*[ti])) Filters: Child: birth-18 years 
#10 Search ((mandatory report*[tiab] OR mandated report*[tiab] OR mandatory 
notif*[tiab] OR mandated notif*[tiab])) OR (mandat*[ti] AND (report*[ti] OR 
notif*[ti])) 
#11 Search ((mandatory report*[tiab] OR mandated report*[tiab] OR mandatory 
notif*[tiab] OR mandated notif*[tiab])) OR (mandat*[ti] AND (report*[ti] OR 
notif*[ti])) Filters: Systematic Reviews 
#9 Search mandat*[ti] AND (report*[ti] OR notif*[ti]) 
#8 Search mandatory report*[tiab] OR mandated report*[tiab] OR mandatory 
notif*[tiab] OR mandated notif*[tiab] 
#7 Search (((physician*[Title] OR doctor*[Title] OR general practi*[Title] OR family 
physician*[Title] OR "primary care"[Title]))) AND ((educat*[Title] OR learn*[Title] 
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OR teach*[Title] OR train*[Title])) Filters: Systematic Reviews; published in the last 
10 years; English 
#6 Search (((physician*[Title] OR doctor*[Title] OR general practi*[Title] OR family 
physician*[Title] OR "primary care"[Title]))) AND ((educat*[Title] OR learn*[Title] 
OR teach*[Title] OR train*[Title])) Filters: Systematic Reviews; English 
#5 Search (((physician*[Title] OR doctor*[Title] OR general practi*[Title] OR family 
physician*[Title] OR "primary care"[Title]))) AND ((educat*[Title] OR learn*[Title] 
OR teach*[Title] OR train*[Title])) Filters: Systematic Reviews 
#4 Search (((physician*[Title] OR doctor*[Title] OR general practi*[Title] OR family 
physician*[Title] OR "primary care"[Title]))) AND ((educat*[Title] OR learn*[Title] 
OR teach*[Title] OR train*[Title])) 
#3 Search (educat*[Title] OR learn*[Title] OR teach*[Title] OR train*[Title]) 
#2 Search (physician*[Title] OR doctor*[Title] OR general practi*[Title] OR family 
physician*[Title] OR "primary care"[Title]) 
Web of Science (Core Collection) 
# 29 8 #25 AND #23 
# 28 88 #27 AND #10 
# 27 521 #23 AND #21 
# 26 63 TS=("prevent strateg*" OR "prevent program*") 
# 25 165 TS=("prevent strateg*" OR "prevent program*") 
# 24 521 #23 AND #21 
# 23 1,576,775 TS=(physician* OR doctor* OR "general practi" OR "family practi*" OR 
"primary care" OR healthcare OR "health care") OR TI=(health* OR 
medicine* OR nurs*) 
# 22 2 #21 AND #12 
# 21 5,487 #20 OR #19 
# 20 1,960 TS=((relig* OR muslim* OR islam* or "far right") NEAR/5 (extremis* OR 
terror* or radicalisation OR radicalization)) 
# 19 3,531 TS=("home office" OR "illegal migrant*" OR "illegal immigra*" OR 
"undocumented migran*" OR "undocumented immigran*" OR illegals) 
# 18 363 #15 OR #13 Refined by: PUBLICATION YEARS: ( 2018 OR 2008 OR 2017 OR 
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2016 OR 2015 OR 2014 OR 2013 OR 2012 OR 2011 OR 2010 OR 2009 ) AND 
[excluding] DOCUMENT TYPES: ( EDITORIAL MATERIAL OR MEETING 
ABSTRACT OR BOOK REVIEW OR LETTER OR NEWS ITEM OR PROCEEDINGS 
PAPER ) 
# 17 405 #15 OR #13 Refined by: PUBLICATION YEARS: ( 2018 OR 2008 OR 2017 OR 
2016 OR 2015 OR 2014 OR 2013 OR 2012 OR 2011 OR 2010 OR 2009 ) 
# 16 597 #15 OR #13 
# 15 321 #14 AND #12 
# 14 64,467 TS=((child* OR infant* OR teen* OR adolescen*) NEAR/3 (abuse* OR 
violence OR maltreat*)) OR TI=((child* OR infant* OR teen* OR adolescen*) 
AND (abuse* OR violence OR maltreat*)) OR TS=(safeguarding OR "safe 
guarding") 
# 13 290 #12 AND #10 
# 12 2,582 TOPIC: ((mandat* OR compulsory) NEAR/3 (report* OR notif*)) OR TITLE: 
((mandat* OR compulsory) AND (report* OR notif*)) 
# 11 64 #10 AND #9 
# 10 5,653,563 TOPIC: ("united kingdom" or uk or britain or british or gb or england or 
"northern ireland" or scotland or wales or nhs) OR ADDRESS: ("united 
kingdom" or uk or britain or british or gb or england or "northern ireland" 
or scotland or wales or nhs) 
# 9 787 TOPIC: ("cultural competenc*") AND TOPIC: (physician* OR doctor* OR 
"general practi*" OR "family practi" OR "primary care") 
# 8 128 TITLE: ("cultural competenc*") AND TOPIC: (educat* OR learn* OR teach* 
OR train*) AND TOPIC: (physician* OR doctor* OR "general practi*" OR 
"family practi" OR "primary care") 
# 7 179 TOPIC: ("moral imperative" OR "ethical imperative" OR "emotional 
imperative") AND TOPIC: (educat* OR learn* OR teach* OR train*) 
# 6 4 TOPIC: ("moral imperative" OR "ethical imperative" OR "emotional 
imperative") AND TOPIC: ((child* OR adolecen* OR teen* OR infan*) 
NEAR/5 (abuse* OR violence OR maltreat*)) 
# 5 0 TITLE: ("moral imperative" OR "ethical imperative" OR "emotional 
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imperative") AND TOPIC: ((child* OR adolecen* OR teen* OR infan*) 
NEAR/5 (abuse* OR violence OR maltreat*)) 
# 4 287 TITLE: ("moral imperative" OR "ethical imperative" OR "emotional 
imperative") 
# 3 1 TOPIC: ("moral imperative" OR "ethical imperative" OR "emotional 
imperative") AND TOPIC: (((mandat* OR compulsory) NEAR/2 (report* OR 
notif*))) 
# 2 55 TOPIC: ("moral imperative" OR "ethical imperative" OR "emotional 
imperative") AND TOPIC: (doctor* OR physician* OR "general practi*" OR 
"family practi*") 
# 1 891 TOPIC: ("moral imperative" OR "ethical imperative" OR "emotional 
imperative") 
A total of 88 citations were screened by title and abstract, 36 were screened in full text and 10 were 
included in the final synthesis. 
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Appendix D. Full set of derived CMOC/full programme theory.  
The need for FGM knowledge and awareness: 
1) Lacking knowledge or skills (including about the cultural contexts of FGM, safeguarding requirements, 
who might be affected, and the different types of FGM and their clinical consequences) impacts on 
GPs’ ability to provide optimal care for women affected by FGM Practitioners may not be aware that 
they lack knowledge, including which patients may be affected and their care needs (C). This lack of 
knowledge (M) results in their inability to meet their care needs. (O) (1-23).  
2) Lacking the necessary knowledge and skills (C), is associated with a lack of confidence (M) which 
impacts on clinical care for women with FGM (O) (10, 24, 25). This includes having the knowledge and 
confidence to consider who may be at risk (26).  
3) Feeling that they have adequate knowledge (including how to respond to a disclosure) (C) helped 
clinicians feel confident (M) to ask to ask (O) (27, 28).  
4) Women who perceive healthcare professionals lack knowledge and skills to manage FGM 
(C), or who have experiences stigma (C) may lack confidence that health services (M) will 
meet their care needs (O) (5, 10,24, 29-33). 
5) (C)Health professionals experience emotional reactions to encountering FGM such as anger, shock, 
and pity; they find encountering FGM without adequate knowledge is “frightening”(35)(M). 
Professionals try to hide their reactions but are aware their reaction may be apparent to the women 
(21, 23, 34-37) (O).  
6) Community members see health care providers reacting with shock or horror to their FGM (C). This 
provokes feelings of shame (M) which reduces their likelihood of accessing services (O) (22, 38-42) .  
7) However, clinicians confident in managing FGM (C) are able to reassure women (M) and meet their 
care needs (O) (28, 43, 44).  
8) Healthcare professionals may experience a strong emotional responses to FGM (C). This may make 
them feel panicked or frightened (M) and abandon their usual routines and practices (O) (28, 93). 
9) FGM is usually a relatively small part of the GP workload (C). GPs may not identify learning about FGM 
as a priority (M) for themselves. The GPs then lack knowledge and skills (O)(45,46). 
10) Clinicians who encounter FGM more frequently in the line of their work (C), may become sensitised to 
FGM (M) and motivated (M) to learn more or develop their knowledge and skills (O). The converse 
may also be true (8, 12, 14, 47). 
11) FGM can be difficult to correctly identify (48), especially types 1 and 4 and associated with less 
symptoms (C) and GPs may not have the expertise or confidence (M) to correctly identify or manage 
FGM (O) (20, 49-53).  
 
Talking about FGM and communication: 
12) A key skill GPs need is being able to talk about FGM sensitively ). Fears (M) of offending women by not 
knowing how to raise the issue(C) can lead GPs to avoid talking about FGM (O) (4,, 10, 16, 21, 22, 23, 
29, 35, 48, 54-57) . 
13) Professionals who understand that FGM can be sensitive or taboo subject (C) may be fearful of 
offending women (M) and avoid discussing FGM with women (O) (23,29,54, 55, 58,59).  This 
contextual factor may be evolving as community attitudes towards the practice of FGM change 
including meaning that talking about FGM is less taboo in some communities (37, 60-64, 92).  
14) Not being aware of or not recognising evolving community practices (C) risks (M) offending 
community members thereby reducing effective communication/consultations (O) (37). Or that 
professionals are not able to accurately appraise risk (11) (61).  
15) Raising FGM in a way that is normalised within the consultation, for example as a standard question 
on an assessment form (C) may reduce the embarrassment (M) and facilitate asking (O) (23). Prompts 
in the records may help clinicians to do this (23, 65).  
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16) Challenges around the use of terminology can complicate communication between GPs and their 
patients affected by FGM. Some women may find the terms FGM offensive or frightening , or if 
the term FGM is not familiar to the woman (C) ), or she does not align her cultural practice (for 
example labial elongation) with FGM (C), then she may not relate her experience to FGM (M) or know 
how to reply if a GP asks her about FGM(O)  (O) (66-70). 
17) Women’s experiences of poor communication and difficulties in engagement with health 
professionals (e.g. language, cultural differences, perceived judgement), and including non-
verbal communication, led to them feeling not understood or respected (M), causing a lack 
of confidence and trust in health services (O) (21, 29, 30, 39, 71, 72).  
18) Women who feel pitied or judged(C) may be reluctant (M) to make a disclosure to a health 
care professional (O) (73, 74).  
19) Members of communities affected by FGM acting as health advocates (C) may help promote 
trust and educate communities and professionals (M) to facilitate access to services (O) (75-
77).  
20) Language barriers and a lack of understanding of how the health setting works, including 
communicating with primary care receptionists (C) can make accessing services difficult or 
stressful (M) and lead to avoidance (O) (78). 
21)  Whether FGM is relevant to the health concern which the woman brings to her GP appointment (C), 
could impact on whether  the GP or woman are willing to raise or discuss FGM (M), and  how such a 
conversation may be received or experienced (O) (36, 37, ,60, 67, 79). This may apply when GPs 
consider asking women about FGM to consider safeguarding needs within their families, rather than 
because of their own health needs (27, 37, 80,81)) .  
22) Coding FGM into medical records introduces potential tensions around balancing the needs of the 
woman (and her confidentiality) with the potential need of her family (C) which may cause confusion 
or uncertainty for GPs (M), and lead to improvised strategies or inconsistent coding (O) (81- 83). 
23) Women who perceive that the HCP is preoccupied with their FGM (C), can feel disrespected (M) and 
disengage with health care settings (O) (37,60, 84, 85) .  
24) GPs gender (C) may influence whether the woman or GP feel it is culturally appropriate (M) to talk 
about FGM (O) (23,38, 55, 86).  
25) Time pressures in the consultation (C) mean GPs may be reluctant (M) to discuss FGM (O). (23, 46, 55, 
87) 
26) Language barriers are a significant context which influence the conversations between GPs and 
women about FGM (C) which reduce communication (M) between women and GPs with impacts on 
communication effectiveness and their care (O) (4, 17, 21,23, 29, 55, 57, 58, 78, 86, 88).  
27) Strategies to address language barriers add their own complications. Official interpreters are 
recommended, but may not be available or trusted by women, for example if they both perceive FGM 
as taboo, or she fears they will not respect her confidentiality. This can lead to fear (M) and reduced 
engagement with health professionals (O) (4, 6, 17, 23,29, 35, 36, 38, 55,56, 89,90). 
28) The presence of family members (as interpreters, or witnesses) in the consultation (C) may inhibit GPs 
feeling able to raise FGM (O) with the women, because of concerns about privacy and confidentiality 
(M) (4, , 55, 58, 91).  
 
 
The need for guidelines and access to specialist services: 
29) Researchers and commentators suggest that having access to clear and supportive guidelines about 
what clinicians should do (C) will enable professionals (M) to ask women about FGM and optimise 
their care (O)(19, 20,35,92,93). Even when guidelines exist, awareness of them may be incomplete, or 
they may not be followed, as demonstrated by four UK hospital studies (47, 56, 57, 94). The reasons 
for this in the case of FGM warrant exploration. Having prompts to normalise asking about FGM may 
help clinicians broach the subject (95), especially if linked to training or referral pathways(96).  
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30) FGM is a complex area for health care professionals to manage, and this management may include 
needing to report women and their families to other authorities. If professionals are developing 
awareness of FGM, without accompanying guidance (C), they may experience uncertainty and face 
what they experience as ethical tensions (M) and risk making incorrect or uncertain decisions 
regarding reporting (O) (92,93) 
31) Lacking guidance, including guidelines and certainty about what good care comprises (C) can lead to 
practitioners feeling uncertain (M) and improvising how they offer care (O) (22, 23).  
32) Knowing how to react or having access to specialist services (C) may help GPs and community 
members feel confident (M) to talk about FGM (O) (23, 29, 52, 53, 72, 97).  
33) When Health care professionals speak about FGM within a framework of offering support and 
services (C), it is more likely to be experienced as acceptable by the woman (M, O) (64). 
34)  Training is more likely to be effective (C) in changing behaviour and promoting asking (O) when it is 
supported by resources and referral pathways or protocol for intervention (M) (28, 73, 96, 98). 
Specialist access may be especially important to support practitioners in low prevalence areas (23). 
 
Mandated actions including mandatory reporting and the FGM Enhanced dataset requirements: 
35) The mandatory reporting duty (C) may cause distress and reduce trust (M) in professionals which may 
deter women from seeking help or disclosing their FGM (O) (52, 55, 60, 62, 99-101). 
36) Concerns that medical encounters or records are not confidential may cause fear/apprehension (M) 
and deter women from a disclosure of her needs or concerns (O) (46, 91, 102).  
37) The requirement to submit personally identifiable data to the FGM enhanced dataset (C) may reduce 
women’s trust in the confidentiality of the GP consultation (M) and make her reluctant to disclose 
FGM (O) or make GPs reluctant to raise FGM (O) because of concerns about confidentiality (M) (55, 
60,  75, 103-106).  
38) The ways in which mandatory reporting or the enhanced dataset are raised in the consultation, 
including when this happens repeatedly (C), may lead women to feel that the professionals’ interest 
in more in data collection than them, or make them feel judged or fearful (M), and avoid attending 
healthcare altogether (O) (60) 
39) The concern (M) that making a mandated report (C) would have a potentially negative impact on trust 
(O) in on-going professional relationships (O) was an important potential consideration for 
professionals (107-110) and identified as a potential deterrent for help seeking (108,111). 
40) Another concern about managing the legislative requirements includes that FGM can be difficult to 
identify on examination. GPs may feel that they do not have the skills needed to identify or manage 
FGM and so not feel confident in being able to identify FGM to confidently code it (O)(48-50) (46), 
which may impact on data accuracy (O) (112). Education (C) is needed to help practitioners feel able 
(M) to approach mandatory reporting (O) (122). 
41) Practitioners making mandated reports need to feel confident that their report will be adequately 
responded to, without causing harm (113-114). They may be helped by training (113). 
42)  In addition to lack of knowledge or training (C), practitioners may have concerns about confidentiality 
(C/M) or fear of causing stigma (C/M) which leads to incomplete or inaccurate coding of FGM (115). 
Practitioners may perceive a need to feel certain (C) before making a mandated report (O) so that 
they do not risk making a mistake (M)(116-117). 
43) When young people know that the professional whom they are speaking to is mandated to share the 
information with other authorities (C), they may feel more reluctant to trust the professional (M), and 
less likely to make a disclosure (O) (118). 
44) A Perceptions of how trustworthy the authority being referred onto may contribute to decisions as to 
whether or not to disclose. Those who are potentially fearful of authorities or perceive themselves to 
be vulnerable (C), for example those with uncertain migrant status (C), or if they fear that their 
disclosure risks placing others at risk of trouble (c), may be more fearful of mandatory reporting or 
data sharing (M) and avoid accessing services (O) (107)(119-124) 
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